var title_f17_35_17968="Acid fast stain skin biopsy";
var content_f17_35_17968=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F55248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F55248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acid fast stain skin biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17968=[""].join("\n");
var outline_f17_35_17968=null;
var title_f17_35_17969="Calculator: Calcium correction in hypoalbuminemia";
var content_f17_35_17969=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"CalciumAlbumin_form\" name=\"CalciumAlbumin_form\" onkeydown=\"clrResults();\" onkeyup=\"CalciumAlbumin_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Calcium correction in hypoalbuminemia",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <div id=\"calc_equation\">",
"      <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"       <tr>",
"        <td align=\"left\" bgcolor=\"#6c9a9c\">",
"         <span class=\"medCalcFontFormuli\">",
"          Ca = SerumCa + 0.8 * (NormalAlbumin - PatientAlbumin)",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"     </div>",
"    </center>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Serum Ca",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Serum_Ca_param\" onblur=\"CalciumAlbumin_fx(); minMaxCheck();\" onchange=\"CalciumAlbumin_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Serum_Ca_unit\" onchange=\"CalciumAlbumin_fx();\" style=\"width:105px;\">",
"              <option value=\"100|0|gm/L\">",
"               gm/L",
"              </option>",
"              <option value=\"1000|0|gm/dL\">",
"               gm/dL",
"              </option>",
"              <option value=\"1|0|mg%\">",
"               mg%",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|mg/dL\">",
"               mg/dL",
"              </option>",
"              <option value=\"100|0|mg/mL\">",
"               mg/mL",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" valign=\"top\">",
"             <span class=\"medCalcFontOneBold\">",
"              Normal Albumin",
"             </span>",
"            </td>",
"            <td align=\"left\" colspan=\"2\">",
"             <span class=\"medCalcFontOne\">",
"              <input checked=\"checked\" name=\"Normal_Albumin_radio\" onclick=\"CalciumAlbumin_fx();\" type=\"radio\" value=\"4 gm/dL|4\"/>",
"              4 gm/dL",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"left\">",
"             <br/>",
"            </td>",
"            <td align=\"left\" colspan=\"2\">",
"             <span class=\"medCalcFontOne\">",
"              <input name=\"Normal_Albumin_radio\" onclick=\"CalciumAlbumin_fx();\" type=\"radio\" value=\"4.4 gm/dL|4.4\"/>",
"              4.4 gm/dL",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Patient Albumin",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Patient_Albumin_param\" onblur=\"CalciumAlbumin_fx(); minMaxCheck();\" onchange=\"CalciumAlbumin_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Patient_Albumin_unit\" onchange=\"CalciumAlbumin_fx();\" style=\"width:105px;\">",
"              <option value=\"0.1|0|gm/L\">",
"               gm/L",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|gm/dL\">",
"               gm/dL",
"              </option>",
"              <option value=\"0.001|0|mg%\">",
"               mg%",
"              </option>",
"              <option value=\"0.001|0|mg/dL\">",
"               mg/dL",
"              </option>",
"              <option value=\"0.1|0|mg/mL\">",
"               mg/mL",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Result:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Ca",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Ca_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"Ca_unit\" onchange=\"CalciumAlbumin_fx();\" style=\"width:105px;\">",
"               <option value=\"100|0|gm/L\">",
"                gm/L",
"               </option>",
"               <option value=\"1000|0|gm/dL\">",
"                gm/dL",
"               </option>",
"               <option value=\"1|0|mg%\">",
"                mg%",
"               </option>",
"               <option selected=\"selected\" value=\"1|0|mg/dL\">",
"                mg/dL",
"               </option>",
"               <option value=\"100|0|mg/mL\">",
"                mg/mL",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"center\" colspan=\"3\">",
"             <span class=\"medCalcFontOneBold\">",
"              Decimal Precision:",
"             </span>",
"             <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"CalciumAlbumin_fx();\">",
"              <option>",
"               0",
"              </option>",
"              <option>",
"               1",
"              </option>",
"              <option selected=\"selected\">",
"               2",
"              </option>",
"              <option>",
"               3",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"     </span>",
"    </div>",
"    <div id=\"calc_notes\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       The",
"       <b>",
"        Normal Albumin",
"       </b>",
"       parameter is set to 4 gm/dL",
"      </li>",
"      <li>",
"       Some practitioners prefer 4.4 gm/dL as normal (see article 1 below.)  Simply change the",
"       <b>",
"        Normal Albumin",
"       </b>",
"       value above and the page will recalculate instantly.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Figge J, Jabor A, Kazda A, Fencl V. Anion gap and hypoalbuminemia.",
"        <i>",
"         Crit Care Med",
"        </i>",
"        . 1998 Nov;26(11):1807-10.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum  proteins.",
"        <i>",
"         Br Med J",
"        </i>",
"        . 1973 Dec 15;4(5893):643-6.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17969=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function CalciumAlbumin_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.CalciumAlbumin_form){",
"",
"",
"doCalc = true;",
"if (Serum_Ca_param.value.indexOf(',') >= 0){ Serum_Ca_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Serum_Ca_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Serum_Ca_unit.options[Serum_Ca_unit.selectedIndex].value.split('|');",
"Serum_Ca = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Normal_Albumin_radio[0].checked){ Normal_Albumin = 4; }",
"if (Normal_Albumin_radio[1].checked){ Normal_Albumin = 4.4; }",
"if (Patient_Albumin_param.value.indexOf(',') >= 0){ Patient_Albumin_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Patient_Albumin_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Patient_Albumin_unit.options[Patient_Albumin_unit.selectedIndex].value.split('|');",
"Patient_Albumin = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = decpts.options[decpts.selectedIndex].text;",
"Ca =  Serum_Ca + 0.8 * (Normal_Albumin - Patient_Albumin);",
"",
"unit_parts = Ca_unit.options[Ca_unit.selectedIndex].value.split('|');",
"if (doCalc) Ca_param.value = fixDP((Ca - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.CalciumAlbumin_form){",
"",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.CalciumAlbumin_form){",
"",
"Ca_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f17_35_17969=null;
var title_f17_35_17970="CW Doppler pulmonary vein MR";
var content_f17_35_17970=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F62749&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F62749&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary vein flow in severe mitral regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 254px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The continuous wave Doppler, obtained from the pulmonary vein (PV), shows systolic flow reversal or retrograde systolic flow, which is the hallmark of severe mitral regurgitation (MR) and is the flow analogue of the v-wave seen on the pulmonary artery catheter wedge pressure tracing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17970=[""].join("\n");
var outline_f17_35_17970=null;
var title_f17_35_17971="Patient information: Peanut allergy (The Basics)";
var content_f17_35_17971=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/87352\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/41/7824\">",
"         Hives",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/55/32626\">",
"          Angioedema of the lips and tongue",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/44/11975\">",
"           Using an epinephrine auto-injector",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?32/30/33250\">",
"         Patient information: Anaphylaxis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/31/1523\">",
"         Patient information: Angioedema (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/30/6626\">",
"         Patient information: Eczema (atopic dermatitis) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/54/39778\">",
"         Patient information: Eosinophilic esophagitis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/57/29586\">",
"         Patient information: Epinephrine auto-injectors (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/27/35250\">",
"         Patient information: Food allergy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/47/37617\">",
"         Patient information: Hives (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?14/57/15250\">",
"         Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/23/15730\">",
"         Patient information: Atopic dermatitis (eczema) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/47/29429\">",
"         Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/30/28134\">",
"         Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Peanut allergy (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H176796792\">",
"      <span class=\"h1\">",
"       What is a peanut allergy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A peanut allergy is when a person&rsquo;s immune (infection-fighting) system responds as if peanuts are harmful to the body. If a person eats, breathes in, or touches peanuts, he or she can have an allergic reaction.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176796853\">",
"      <span class=\"h1\">",
"       What are the symptoms of an allergic reaction?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Common symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Hives, which are raised, red patches of skin that are itchy (",
"        <a class=\"graphic graphic_picture graphicRef79242 \" href=\"UTD.htm?7/41/7824\">",
"         picture 1",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Puffiness of the face, eyelids, ears, mouth, hands, or feet",
"       </li>",
"       <li>",
"        Swelling of the tongue (",
"        <a class=\"graphic graphic_picture graphicRef73131 \" href=\"UTD.htm?31/55/32626\">",
"         picture 2",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Trouble breathing, noisy breathing (wheezing), or coughing",
"       </li>",
"       <li>",
"        Nausea, vomiting, or diarrhea",
"       </li>",
"       <li>",
"        Feeling dizzy or passing out",
"       </li>",
"       <li>",
"        Death (although this is rare)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      A severe allergic reaction is also called &ldquo;anaphylaxis.&rdquo; When people have anaphylaxis, they can get very sick, very quickly.",
"     </p>",
"     <p>",
"      Although less common, a peanut allergy also sometimes causes:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Eczema &ndash; This is a skin condition that makes the skin itchy and flaky.",
"       </li>",
"       <li>",
"        Eosinophilic esophagitis &ndash; This is a condition that makes it hard to swallow food or causes heartburn.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176796868\">",
"      <span class=\"h1\">",
"       Is there a test for a peanut allergy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse will ask about the foods you eat and the symptoms you have. He or she will also do a test to check for a peanut allergy. Tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A skin test &ndash; For this test, a doctor or nurse will put a tiny drop of peanut on your skin and make a tiny prick in your skin. Then he or she will watch your skin to see if you get a red, itchy bump.",
"       </li>",
"       <li>",
"        A blood test to look for a peanut-specific antibody (protein) called &ldquo;IgE&rdquo;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people have a test called a food challenge. This involves eating a small amount of peanut and seeing whether it causes symptoms. For safety reasons, this test is done only in a doctor&rsquo;s office or hospital.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176796883\">",
"      <span class=\"h1\">",
"       How is a peanut allergy treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;As of now, there is no cure for a peanut allergy.",
"     </p>",
"     <p>",
"      Allergic reactions to peanuts are usually treated with medicine called epinephrine. Epinephrine comes in a device called an auto-injector. This device gives you a shot of epinephrine (",
"      <a class=\"graphic graphic_picture graphicRef75436 \" href=\"UTD.htm?11/44/11975\">",
"       picture 3",
"      </a>",
"      ). When your doctor prescribes an auto-injector, he or she will show you how to use it. Keep your auto-injector with you at all times. If you have an allergic reaction to peanuts, use your auto-injector right away and then call",
"      <strong>",
"       9-1-1 for an ambulance",
"      </strong>",
"      .",
"     </p>",
"     <p>",
"      If you do not have an epinephrine auto-injector and have an allergic reaction, call",
"      <strong>",
"       9-1-1 for an ambulance.",
"      </strong>",
"      Do not try to get yourself to the hospital. In the hospital, doctors will give you epinephrine and other medicines.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176796915\">",
"      <span class=\"h1\">",
"       How can I prevent an allergic reaction?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The only way to prevent an allergic reaction is to completely avoid eating peanuts or foods with peanuts in them. To know whether a food contains peanuts, you will need to read its ingredient label. Some countries (including the United States) have laws that make companies clearly list whether a food has peanuts in it.",
"     </p>",
"     <p>",
"      Some foods have warning labels for food allergies, such as &ldquo;May contain peanuts.&rdquo; These foods might have been made on machines or in factories that also made other foods with peanuts. Doctors usually recommend that people with a peanut allergy avoid these foods.",
"     </p>",
"     <p>",
"      Foods that are especially likely to contain peanuts include baked goods and Asian, African, and Mexican foods. If you eat at a restaurant, bakery, or ice cream parlor, be sure to tell your server about your peanut allergy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176796930\">",
"      <span class=\"h1\">",
"       What else should I know if I have a peanut allergy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with a peanut allergy:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Can have an allergic reaction if they share saliva with (kiss) someone who ate peanuts and did not brush his or her teeth afterward",
"       </li>",
"       <li>",
"        Cannot have an allergic reaction by only smelling peanut butter",
"       </li>",
"       <li>",
"        Might have an allergic reaction by breathing in peanut dust or peanut protein, for example, when someone cooks with peanuts (if they are very allergic)",
"       </li>",
"       <li>",
"        Sometimes have allergies to other foods, too, so might need to avoid eating certain other foods",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176796945\">",
"      <span class=\"h1\">",
"       What if my child has a peanut allergy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your child has a peanut allergy, let his or her caregivers, schools, and camps know. You should:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Tell them which foods your child can and can&rsquo;t eat.",
"       </li>",
"       <li>",
"        Make a plan so they know how to treat an allergic reaction.",
"       </li>",
"       <li>",
"        Make sure they know where your child&rsquo;s epinephrine auto-injector is and how and when to use it.",
"       </li>",
"       <li>",
"        Make sure they know how to reach you or your child&rsquo;s doctor in case of an emergency.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176796960\">",
"      <span class=\"h1\">",
"       Will my child outgrow his or her peanut allergy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most children do not outgrow their peanut allergy, but some do. Your child&rsquo;s doctor will monitor your child&rsquo;s peanut allergy over time to see whether he or she outgrows it.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176796975\">",
"      <span class=\"h1\">",
"       Where can I get more information?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can get more information about peanut allergies (and other food allergies) from the Food Allergy and Anaphylaxis Network. Their Web site is",
"      <a class=\"external\" href=\"file://www.foodallergy.org/\">",
"       www.foodallergy.org",
"      </a>",
"      .",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H176797083\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/27/35250?source=see_link\">",
"       Patient information: Food allergy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/30/33250?source=see_link\">",
"       Patient information: Anaphylaxis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/31/1523?source=see_link\">",
"       Patient information: Angioedema (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/57/29586?source=see_link\">",
"       Patient information: Epinephrine auto-injectors (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/47/37617?source=see_link\">",
"       Patient information: Hives (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/30/6626?source=see_link\">",
"       Patient information: Eczema (atopic dermatitis) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/54/39778?source=see_link\">",
"       Patient information: Eosinophilic esophagitis (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/47/29429?source=see_link\">",
"       Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/57/15250?source=see_link\">",
"       Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=see_link\">",
"       Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?15/23/15730?source=see_link\">",
"       Patient information: Atopic dermatitis (eczema) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?17/35/17971?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87352 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-AA4CF5E739-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17971=[""].join("\n");
var outline_f17_35_17971=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796792\">",
"      What is a peanut allergy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796853\">",
"      What are the symptoms of an allergic reaction?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796868\">",
"      Is there a test for a peanut allergy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796883\">",
"      How is a peanut allergy treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796915\">",
"      How can I prevent an allergic reaction?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796930\">",
"      What else should I know if I have a peanut allergy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796945\">",
"      What if my child has a peanut allergy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796960\">",
"      Will my child outgrow his or her peanut allergy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176796975\">",
"      Where can I get more information?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H176797083\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/87352\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/41/7824\">",
"      Hives",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/55/32626\">",
"       Angioedema of the lips and tongue",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/44/11975\">",
"        Using an epinephrine auto-injector",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/30/33250?source=related_link\">",
"      Patient information: Anaphylaxis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/57/15250?source=related_link\">",
"      Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/31/1523?source=related_link\">",
"      Patient information: Angioedema (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/23/15730?source=related_link\">",
"      Patient information: Atopic dermatitis (eczema) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/30/6626?source=related_link\">",
"      Patient information: Eczema (atopic dermatitis) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/54/39778?source=related_link\">",
"      Patient information: Eosinophilic esophagitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/57/29586?source=related_link\">",
"      Patient information: Epinephrine auto-injectors (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/27/35250?source=related_link\">",
"      Patient information: Food allergy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/47/29429?source=related_link\">",
"      Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/47/37617?source=related_link\">",
"      Patient information: Hives (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=related_link\">",
"      Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_35_17972="Cyclopentolate: Patient drug information";
var content_f17_35_17972=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Cyclopentolate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/34/24100?source=see_link\">",
"     see \"Cyclopentolate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/3/31795?source=see_link\">",
"     see \"Cyclopentolate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F155338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      AK-Pentolate&trade;;",
"     </li>",
"     <li>",
"      Cyclogyl&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F155339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      AK Pentolate Oph Soln;",
"     </li>",
"     <li>",
"      Cyclogyl&reg;;",
"     </li>",
"     <li>",
"      Diopentolate&reg;;",
"     </li>",
"     <li>",
"      Minims Cyclopentolate;",
"     </li>",
"     <li>",
"      PMS-Cyclopentolate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691284",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used before an eye exam.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to cyclopentolate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016586\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear sunglasses. Sunlight may bother your eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight. Use care when driving or doing other tasks that call for clear eyesight.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696097",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you by a doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12014 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-9F9DC17642-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17972=[""].join("\n");
var outline_f17_35_17972=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155338\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155339\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016582\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016581\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016586\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016587\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016589\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016584\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016585\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016590\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016591\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/34/24100?source=related_link\">",
"      Cyclopentolate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/3/31795?source=related_link\">",
"      Cyclopentolate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_35_17973="Stool diary sample";
var content_f17_35_17973=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62849%7EPEDS%2F53073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62849%7EPEDS%2F53073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Stool diary (sample)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 602px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 573px\">",
"   <div class=\"ttl\">",
"    Stool diary",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 553px; height: 611px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17973=[""].join("\n");
var outline_f17_35_17973=null;
var title_f17_35_17974="Amanita bisporigera-Destroying angel";
var content_f17_35_17974=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Amanita bisporigera (\"Destroying angel\")",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These&nbsp;tall white to light-tan mushrooms contain cyclopeptides that can cause life-threatening delayed liver toxicity when ingested. They are also sometimes called the \"destroying angel\". This common name is also&nbsp;used to describe&nbsp;three other toxic white Amanita species: A. ocreata, A. virosa and A. verna.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Hollenbaugh.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17974=[""].join("\n");
var outline_f17_35_17974=null;
var title_f17_35_17975="Evaluation of jaundice caused by unconjugated hyperbilirubinemia in children";
var content_f17_35_17975=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of jaundice caused by unconjugated hyperbilirubinemia in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17975/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17975/contributors\">",
"     Oranit Shaked, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17975/contributors\">",
"     Barbara M Pe&ntilde;a, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17975/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17975/contributors\">",
"     Elizabeth B Rand, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17975/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17975/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/35/17975/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Jaundice is a yellowish discoloration of the skin and sclerae that indicates an abnormality of bilirubin metabolism or excretion. The bilirubin can be either unconjugated, in which case it is poorly soluble in water, or conjugated to glucuronic acid, which makes it soluble in water; conjugated bilirubin is also known as \"direct\" bilirubin. Disorders causing unconjugated hyperbilirubinemia are more common in children, and tend to be distinct from those causing conjugated hyperbilirubinemia. However, some diseases increase both unconjugated and conjugated bilirubin because they affect several different aspects of hepatocyte function.",
"   </p>",
"   <p>",
"    Beyond the neonatal period, the normal serum total bilirubin concentration is less than 1",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (17",
"    <span class=\"nowrap\">",
"     micromol/L),",
"    </span>",
"    of which approximately 96 percent is present in unconjugated form. Jaundice usually becomes clinically apparent when the serum bilirubin concentration is greater than 2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (34",
"    <span class=\"nowrap\">",
"     micromol/L),",
"    </span>",
"    which is twice the upper limit of normal.",
"   </p>",
"   <p>",
"    Conjugated hyperbilirubinemia is defined by a serum conjugated bilirubin concentration greater than 1",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (17",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    if the total bilirubin is &lt;5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (85",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    or more than 20 percent of the total bilirubin if the total bilirubin is &gt;5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (85",
"    <span class=\"nowrap\">",
"     micromol/L).",
"    </span>",
"    It is an abnormal finding that requires further evaluation. The differential diagnosis of conjugated hyperbilirubinemia in neonates differs from that in older children and adults, and is discussed in separate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24519?source=see_link\">",
"     \"Approach to neonatal cholestasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7065?source=see_link&amp;anchor=H14#H14\">",
"     \"Classification and causes of jaundice or asymptomatic hyperbilirubinemia\", section on 'Disorders associated with conjugated hyperbilirubinemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will present an overview of the causes of unconjugated hyperbilirubinemia in children and infants beyond the neonatal period and discuss the evaluation of such patients. Management varies with the underlying disease.",
"   </p>",
"   <p>",
"    The evaluation of unconjugated hyperbilirubinemia in neonates and the causes and diagnostic approach for the adult with jaundice, which are somewhat different, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/39/11898?source=see_link\">",
"     \"Evaluation of unconjugated hyperbilirubinemia in term and late preterm infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/50/42790?source=see_link\">",
"     \"Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7065?source=see_link\">",
"     \"Classification and causes of jaundice or asymptomatic hyperbilirubinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES OF UNCONJUGATED HYPERBILIRUBINEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three basic pathophysiologic mechanisms are mainly responsible for unconjugated hyperbilirubinemia (",
"    <a class=\"graphic graphic_algorithm graphicRef51621 \" href=\"UTD.htm?35/12/36047\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bilirubin overproduction",
"     </li>",
"     <li>",
"      Impaired hepatic bilirubin uptake",
"     </li>",
"     <li>",
"      Impaired hepatic bilirubin conjugation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For older infants and children, the most common causes of unconjugated hyperbilirubinemia are hemolytic processes resulting in bilirubin overproduction (",
"    <a class=\"graphic graphic_table graphicRef66972 \" href=\"UTD.htm?33/19/34108\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Bilirubin overproduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bilirubin overproduction can result from increased breakdown of hemoglobin and other heme-containing proteins. Extravascular and intravascular hemolysis enhance heme catabolism, thereby leading to excess unconjugated bilirubin. In patients with normal liver function, the serum bilirubin concentration caused by hemolysis will rarely exceed 4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (68.4",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/1\">",
"     1",
"    </a>",
"    ]. However, hemolysis can lead to severe hyperbilirubinemia in patients with concurrent liver disease, even if mild.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Extravascular hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extravascular hemolysis is mainly due to extravasation of blood into tissues (hematomas, pulmonary blood, and other collections of extravasated blood) and hypersplenism of various causes (including splenic sequestration in sickle cell disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Intravascular hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of intravascular hemolysis in children are inherited red blood cell disorders: hemoglobinopathies (eg, sickle cell disease and related disorders), disorders of hemoglobin chain synthesis (the thalassemias), erythrocyte membrane defects (hereditary spherocytosis, hereditary elliptocytosis, and related disorders), and erythrocyte enzyme deficiencies (eg, glucose-6-phosphate dehydrogenase deficiency, G6PD). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42170?source=see_link\">",
"     \"Overview of the clinical manifestations of sickle cell disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of the thalassemias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/1/20506?source=see_link\">",
"     \"Hereditary spherocytosis: Clinical features; diagnosis; and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/25/4505?source=see_link\">",
"     \"Clinical manifestations of glucose-6-phosphate dehydrogenase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of intravascular hemolysis include infection, and autoimmune, microangiopathic, and drug-induced hemolytic anemias. Infections that may trigger hemolysis include bacterial sepsis and malaria. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=see_link\">",
"     \"Autoimmune hemolytic anemia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other pathways leading to bilirubin overproduction include dyserythropoiesis (eg, megaloblastic and sideroblastic anemias) and enhanced erythropoiesis due to stress. The mechanisms underlying heme metabolism in these disorders are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7065?source=see_link\">",
"     \"Classification and causes of jaundice or asymptomatic hyperbilirubinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Impaired hepatic bilirubin uptake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impaired delivery of bilirubin to the liver and disorders affecting bilirubin uptake by hepatocytes result in reduced hepatic bilirubin uptake.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Reduced hepatic blood flow",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conditions causing reduced hepatic blood flow and delivery of bilirubin to hepatocytes include heart failure and portosystemic shunts (spontaneously occurring collaterals in cirrhosis or surgical shunts). The hyperbilirubinemia caused by these disorders is predominantly unconjugated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of several drugs (eg, rifamycin antibiotics,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/7/11382?source=see_link\">",
"     probenecid",
"    </a>",
"    , flavaspadic acid, and bunamiodyl, a cholecystographic agent) can impair bilirubin uptake. Such effects will usually resolve within 48 hours of drug discontinuation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Impaired bilirubin conjugation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gilbert syndrome and Crigler-Najjar syndrome types I and II are among the inherited disorders that cause decreased or absent uridine diphosphoglucuronate glucuronosyltransferase (UGT) activity, an enzyme responsible for bilirubin conjugation with glucuronic acid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Gilbert syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gilbert syndrome is a common cause of unconjugated hyperbilirubinemia in adolescents and adults. Individuals with this condition have reduced bilirubin-UGT activity. They typically present with intermittent episodes of mild jaundice, often triggered by an intercurrent illness, physical exertion, or fasting. Affected individuals have a benign prognosis. Given the high frequency of this mutation and lack of pathologic consequences, it may be considered a normal variant. Thus, management is directed at establishing the diagnosis of this disorder and thereby avoiding unnecessary evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42359?source=see_link\">",
"     \"Gilbert's syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Crigler-Najjar syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Crigler-Najjar syndrome types I and II are characterized by the absence or deficiency of the enzyme bilurubin-UGT, respectively. Type I is the more severe form, which presents soon after birth and is associated with severe morbidity and mortality. Type II is the milder form and typically presents in infancy or later childhood, but may appear as late as adolescence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/3/6201?source=see_link\">",
"     \"Crigler-Najjar syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Jaundice is occasionally associated with hyperthyroidism, perhaps because hyperthyroidism inhibits bilirubin glucuronidation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/2\">",
"     2",
"    </a>",
"    ]. As an example, a case series in adults described four patients with hyperthyroidism and unconjugated hyperbilirubinemia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/3\">",
"     3",
"    </a>",
"    ]. The patients had no evidence of heart failure, occult hemolysis, ineffective erythropoiesis, or structural hepatocellular abnormalities, and the serum bilirubin normalized with the attainment of euthyroidism. Rarely, jaundice has been reported in neonates with congenital hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/6/97?source=see_link\">",
"     \"Evaluation and management of neonatal Graves' disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since most patients with hyperthyroidism do not develop jaundice, it has been postulated that these patients also have an underlying defect in bilirubin metabolism (such as Gilbert syndrome) that was unmasked by superimposed hyperthyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some drugs inhibit bilirubin glucuronidation, including several protease inhibitors used to treat HIV disease,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"     ketoconazole",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/32/7687?source=see_link\">",
"     amitriptyline",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Ethinyl estradiol alone competitively inhibits glucuronidation, whereas combination oral contraceptives typically increase UGT activity and promote glucuronidation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic liver diseases cause hyperbilirubinemia through several different mechanisms, which may include disruption of bilirubin conjugation. Examples include chronic persistent hepatitis, advanced cirrhosis, and Wilson disease, in which excessive copper accumulation causes hepatocyte injury and neuropsychiatric disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13910?source=see_link\">",
"     \"Epidemiology and pathogenesis of Wilson disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial laboratory evaluation of a child presenting with jaundice should begin with measurement of the total serum bilirubin with fractionation (conjugated and unconjugated bilirubin), followed by serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and a complete blood count (CBC) with reticulocyte count and microscopic examination of the blood smear. Acutely ill-appearing children should be evaluated promptly for sepsis. If the serum bilirubin level is not elevated, the jaundiced appearance may represent carotenemia, which should also be distinguishable from jaundice during a physical examination. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Physical examination'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The presence or absence of anemia will determine the likely diagnostic possibilities in the well-appearing child with unconjugated hyperbilirubinemia. Algorithmic approaches are provided for evaluating the child with unconjugated hyperbilirubinemia with anemia (",
"    <a class=\"graphic graphic_algorithm graphicRef52931 \" href=\"UTD.htm?40/49/41744\">",
"     algorithm 2",
"    </a>",
"    ) or without anemia (",
"    <a class=\"graphic graphic_algorithm graphicRef72921 \" href=\"UTD.htm?6/22/6510\">",
"     algorithm 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A different approach is warranted if the child with unconjugated hyperbilirubinemia has a substantial conjugated fraction of bilirubin (serum conjugated bilirubin concentration greater than 1",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [17",
"    <span class=\"nowrap\">",
"     micromol/L]",
"    </span>",
"    if the total bilirubin is &lt;5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [85",
"    <span class=\"nowrap\">",
"     micromol/L],",
"    </span>",
"    or more than 20 percent of the total bilirubin if the total bilirubin is &gt;5",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"    Causes of conjugated hyperbilirubinemia include biliary obstruction (eg, gallstones), liver disease causing hepatocyte dysfunction (eg, hepatitis, sepsis, or hepatotoxic drugs), and several inherited disorders such as Dubin-Johnson syndrome or Rotor syndrome. In addition, some disorders, including sickle cell disease, can present with either unconjugated or conjugated hyperbilirubinemia, depending upon the presence of infection, biliary obstruction, or hepatocyte injury that prevents efficient conjugation and clearance of bilirubin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7065?source=see_link&amp;anchor=H14#H14\">",
"     \"Classification and causes of jaundice or asymptomatic hyperbilirubinemia\", section on 'Disorders associated with conjugated hyperbilirubinemia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/7/8314?source=see_link\">",
"     \"Inherited disorders associated with conjugated hyperbilirubinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The causes of conjugated hyperbilirubinemia in neonates are somewhat different, calling for a different approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/50/16169?source=see_link\">",
"     \"Causes of neonatal cholestasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24519?source=see_link\">",
"     \"Approach to neonatal cholestasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     HISTORY AND PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of unconjugated hyperbilirubinemia is broad and requires a thorough history and physical examination as part of the initial evaluation (",
"    <a class=\"graphic graphic_table graphicRef66972 \" href=\"UTD.htm?33/19/34108\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A general clinical history is the first step in the evaluation of the child with unconjugated hyperbilirubinemia. Attention should focus on the following historical details:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age of the patient at first presentation",
"     </li>",
"     <li>",
"      History of inherited disorder (including liver diseases and hemolytic disorders), including a family history of jaundice or anemia",
"     </li>",
"     <li>",
"      Racial or ethnic origin",
"     </li>",
"     <li>",
"      History of",
"      <span class=\"nowrap\">",
"       medication/toxic",
"      </span>",
"      exposure",
"     </li>",
"     <li>",
"      Dietary history (appetite, carotene intake, fava bean ingestion if G6PD suspected)",
"     </li>",
"     <li>",
"      Travel history",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first part of the physical examination is noting the general appearance of the patient. This will help determine whether the patient has a serious underlying condition.",
"   </p>",
"   <p>",
"    Jaundice usually becomes clinically apparent when the serum bilirubin concentration is greater than 2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (34",
"    <span class=\"nowrap\">",
"     micromol/L),",
"    </span>",
"    which is twice the upper limit of normal beyond the neonatal period. The sclera and skin should be examined closely under adequate light. The palms and soles of patients with dark skin are less pigmented and may be easier to evaluate for jaundice or pallor [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/6\">",
"     6",
"    </a>",
"    ]. Pallor may indicate anemia secondary to hemolysis or blood loss.",
"   </p>",
"   <p>",
"    Jaundice may be confused with carotenemia. Carotenemia is usually found in infants and toddlers whose diets consist of large amounts of strained yellow vegetables, particularly carrots. Unlike jaundice, the sclerae are not discolored. In carotenemia, the skin color characteristically is more yellow-orange rather than yellow, and more noticeable over the palms and soles. Although the diet is a major cause of carotenemia in childhood, other causes include nephrotic syndrome, diabetes mellitus, anorexia nervosa, liver disease, and hypothyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/30/34280?source=see_link&amp;anchor=H10#H10\">",
"     \"The pediatric physical examination: Back, extremities, nervous system, skin, and lymph nodes\", section on 'Skin color'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other findings on physical examination may point to a particular cause:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Large areas of bruising or hematoma formation suggest extravascular hemolysis as the cause of the unconjugated hyperbilirubinemia.",
"     </li>",
"     <li>",
"      Organomegaly may indicate underlying organ dysfunction. Splenomegaly may indicate a hypersplenic state such as splenic sequestration in sickle cell disease, or autoimmune hemolysis as may occur in systemic lupus erythematosis (SLE).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     LABORATORY TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum total bilirubin measurement with fractionation is the first test in the evaluation of the patient with jaundice. Transcutaneous bilirubin devices provide useful measures of bilirubin levels in neonates, but do not distinguish between conjugated and unconjugated bilirubin [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/7\">",
"     7",
"    </a>",
"    ]. This technique has not been validated in older infants and children, and is not recommended for use beyond the neonatal period.",
"   </p>",
"   <p>",
"    If unconjugated hyperbilirubinemia is confirmed, further testing is warranted to determine the underlying etiology. This includes complete blood count (CBC) and reticulocyte count. Serum aminotransferases should also be measured. Elevated values suggest the presence of liver disease and measurement of the prothrombin time and partial thromboplastin time may be warranted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34090?source=see_link\">",
"     \"Approach to the patient with abnormal liver biochemical and function tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Anemia and/or hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with anemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    evidence of hemolysis, a peripheral blood smear should be examined microscopically and a Coombs' test should be performed to look for evidence of autoimmune hemolysis (",
"    <a class=\"graphic graphic_algorithm graphicRef52931 \" href=\"UTD.htm?40/49/41744\">",
"     algorithm 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=see_link\">",
"     \"Evaluation of the peripheral blood smear\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=see_link\">",
"     \"Autoimmune hemolytic anemia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sickle cells, spherocytes or elliptocytes suggest a specific red blood cell disorder.",
"     </li>",
"     <li>",
"      Helmet cells or fragmented cells are diagnostic of a microangiopathic hemolytic anemia, as may be seen in hemolytic-uremic syndrome.",
"     </li>",
"     <li>",
"      Nucleated red blood cells and Howell-Jolly bodies indicate a sustained and severe hemolytic process.",
"     </li>",
"     <li>",
"      Red blood cell inclusions (ring forms) may be seen in malaria, but these findings are difficult to detect.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the United States and in most Western European countries, testing for sickle cell disease is performed as a newborn screen, but immigrant children may not have been screened [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/8\">",
"     8",
"    </a>",
"    ]. In the United States the newborn screen is performed for all infants, while other countries employ selective screening, targeting groups considered to be at risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42856?source=see_link\">",
"     \"Diagnosis of sickle cell syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testing for glucose-6-phosphate dehydrogenase deficiency (G6PD) should be considered in children with appropriate risk factors. Boys of African or Mediterranean descent are most likely to have symptomatic disease, which may be triggered by infection or exposure to certain drugs (eg, sulfamethoxazole and some antimalarial agents). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/25/4505?source=see_link\">",
"     \"Clinical manifestations of glucose-6-phosphate dehydrogenase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Absence of anemia or hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients without anemia or evidence of hemolysis who have no laboratory abnormality other than a serum unconjugated bilirubin level less than 5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    probably have Gilbert syndrome (",
"    <a class=\"graphic graphic_algorithm graphicRef72921 \" href=\"UTD.htm?6/22/6510\">",
"     algorithm 3",
"    </a>",
"    ). Confirmation of the diagnosis can be made by detecting a reduction in hepatic bilirubin-UGT activity, which is approximately 30 percent of normal [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. However, this test is not strictly necessary to establish the diagnosis of Gilbert syndrome if the patient is otherwise healthy and has no evidence of hemolysis or liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17975/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42359?source=see_link\">",
"     \"Gilbert's syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with serum unconjugated bilirubin levels well above 5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    should be evaluated for Crigler-Najjar syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/3/6201?source=see_link\">",
"     \"Crigler-Najjar syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of imaging in the evaluation of the patient with unconjugated hyperbilirubinemia is determined based on the history and physical examination findings along with the results of laboratory testing. Imaging of the gallbladder might be considered for patients with hemolytic anemia because of their increased risk for gallstones, particularly if there is any elevation of conjugated bilirubin, suggesting biliary obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/28/21953?source=see_link\">",
"       \"Patient information: Gilbert&rsquo;s syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Jaundice is the clinical finding caused by hyperbilirubinemia, it usually becomes apparent at serum bilirubin concentrations above 2",
"      <span class=\"nowrap\">",
"       mg/dL,",
"      </span>",
"      twice the upper limit of normal. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction and definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In most jaundiced infants and children the hyperbilirubinemia is exclusively or primarily unconjugated. This can be caused by bilirubin overproduction (eg, hemolysis), impaired hepatic bilirubin uptake (eg, reduced hepatic bloodflow or certain drugs), or impaired bilirubin conjugation (eg, Gilbert or Crigler-Najjar syndromes) (",
"      <a class=\"graphic graphic_algorithm graphicRef51621 \" href=\"UTD.htm?35/12/36047\">",
"       algorithm 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef66972 \" href=\"UTD.htm?33/19/34108\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Causes of unconjugated hyperbilirubinemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sepsis can cause hyperbilirubinemia through several mechanisms, including intravascular hemolysis (bilirubin overproduction). Ill-appearing infants and children with jaundice should be evaluated promptly for sepsis, as well as for other possible causes of their hyperbilirubinemia. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gilbert syndrome is a common cause of unconjugated hyperbilirubinemia, particularly in adolescents and adults. It is a heritable defect in bilirubin glucuronidation, and presents with mild transient elevations of unconjugated bilirubin, often triggered by an intercurrent illness. Management is directed at recognition of the disorder and its inconsequential nature, to avoid unnecessary evaluation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Gilbert syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic evaluation should first establish whether the hyperbilirubinemia is unconjugated; if so, the next step is to assess for anemia and hemolysis (",
"      <a class=\"graphic graphic_algorithm graphicRef52931 \" href=\"UTD.htm?40/49/41744\">",
"       algorithm 2",
"      </a>",
"      ). If there is no evidence of hemolysis, the patient should be evaluated for the possibility of underlying liver disease (",
"      <a class=\"graphic graphic_algorithm graphicRef72921 \" href=\"UTD.htm?6/22/6510\">",
"       algorithm 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/1\">",
"      Berk PD, Wolkoff AW, Berlin NI. Inborn errors of bilirubin metabolism. Med Clin North Am 1975; 59:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/2\">",
"      Chowdhury JR, Chowdhury NR, Moscioni AD, et al. Differential regulation by triiodothyronine of substrate-specific uridinediphosphoglucuronate glucuronosyl transferases in rat liver. Biochim Biophys Acta 1983; 761:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/3\">",
"      GREENBERGER NJ, MILLIGAN FD, DEGROOT LJ, ISSELBACHER KJ. JAUNDICE AND THYROTOXICOSIS IN THE ABSENCE OF CONGESTIVE HEART FAILURE. A STUDY OF FOUR CASES. Am J Med 1964; 36:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/4\">",
"      Zhang D, Chando TJ, Everett DW, et al. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation. Drug Metab Dispos 2005; 33:1729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/5\">",
"      Perera MA, Innocenti F, Ratain MJ. Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet? Pharmacotherapy 2008; 28:755.",
"     </a>",
"    </li>",
"    <li>",
"     Mandl, KD. Jaundice-Unconjugated Hyperbilirubinemia. In: Textbook of Pediatric Emergency Medicine, Fleisher, GR, Ludwig, S, Henretig, FM (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia 2006. p. 399.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/7\">",
"      Rubaltelli FF, Gourley GR, Loskamp N, et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics 2001; 107:1264.",
"     </a>",
"    </li>",
"    <li>",
"     National newborn screening status report. Available at: file://www.nlm.nih.gov/medlineplus/newbornscreening.html (Accessed October 29, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/9\">",
"      Black M, Billing BH. Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome. N Engl J Med 1969; 280:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/10\">",
"      Auclair C, Hakim J, Boivin P, et al. Bilirubin and paranitrophenol glucuronyl transferase activities of the liver in patients with Gilbert's syndrome An attempt at a biochemical breakdown of the Gilbert's syndrome. Enzyme 1976; 21:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17975/abstract/11\">",
"      Rudenski AS, Halsall DJ. Genetic testing for Gilbert's syndrome: how useful is it in determining the cause of jaundice? Clin Chem 1998; 44:1604.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5947 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-200.215.4.194-785DB895A1-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17975=[""].join("\n");
var outline_f17_35_17975=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES OF UNCONJUGATED HYPERBILIRUBINEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Bilirubin overproduction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Extravascular hemolysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Intravascular hemolysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Impaired hepatic bilirubin uptake",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Reduced hepatic blood flow",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Impaired bilirubin conjugation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Gilbert syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Crigler-Najjar syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      HISTORY AND PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      LABORATORY TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Anemia and/or hemolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Absence of anemia or hemolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      IMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5947\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5947|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?35/12/36047\" title=\"algorithm 1\">",
"      Classification of unconjugated hyperbilirubinemia in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?40/49/41744\" title=\"algorithm 2\">",
"      Unconjugated bilirubin w anemia child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?6/22/6510\" title=\"algorithm 3\">",
"      Unconjugated bilirubin no anemia child",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5947|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/19/34108\" title=\"table 1\">",
"      Causes unconjugated hyperbilirubinemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24519?source=related_link\">",
"      Approach to neonatal cholestasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34090?source=related_link\">",
"      Approach to the patient with abnormal liver biochemical and function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=related_link\">",
"      Autoimmune hemolytic anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/50/16169?source=related_link\">",
"      Causes of neonatal cholestasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7065?source=related_link\">",
"      Classification and causes of jaundice or asymptomatic hyperbilirubinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=related_link\">",
"      Clinical manifestations and diagnosis of the thalassemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/25/4505?source=related_link\">",
"      Clinical manifestations of glucose-6-phosphate dehydrogenase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/3/6201?source=related_link\">",
"      Crigler-Najjar syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42856?source=related_link\">",
"      Diagnosis of sickle cell syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/50/42790?source=related_link\">",
"      Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13910?source=related_link\">",
"      Epidemiology and pathogenesis of Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/6/97?source=related_link\">",
"      Evaluation and management of neonatal Graves' disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=related_link\">",
"      Evaluation of the peripheral blood smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/39/11898?source=related_link\">",
"      Evaluation of unconjugated hyperbilirubinemia in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42359?source=related_link\">",
"      Gilbert's syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/1/20506?source=related_link\">",
"      Hereditary spherocytosis: Clinical features; diagnosis; and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/7/8314?source=related_link\">",
"      Inherited disorders associated with conjugated hyperbilirubinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42170?source=related_link\">",
"      Overview of the clinical manifestations of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/28/21953?source=related_link\">",
"      Patient information: Gilbert&rsquo;s syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/30/34280?source=related_link\">",
"      The pediatric physical examination: Back, extremities, nervous system, skin, and lymph nodes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_35_17976="Molecular biology of acute promyelocytic leukemia";
var content_f17_35_17976=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Molecular biology of acute promyelocytic leukemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17976/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17976/contributors\">",
"     Wendy Stock, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17976/contributors\">",
"     Michael J Thirman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17976/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17976/contributors\">",
"     Richard A Larson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17976/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17976/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/35/17976/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute myeloid leukemia (AML) refers to a group of hematopoietic neoplasms involving cells committed to the myeloid lineage. Acute promyelocytic leukemia (APL) is a biologically and clinically distinct variant of AML. APL was classified as AML-M3 in the older French-American-British (FAB) classification system and is currently classified as acute promyelocytic leukemia with t(15;17)(q24.1;q21.1);PML-RARA in the WHO classification system [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39720?source=see_link\">",
"     \"Classification of acute myeloid leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cytogenetic hallmark of APL is a translocation involving the retinoic acid receptor-alpha (RAR-alpha, RARa) locus on chromosome 17 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/2\">",
"     2",
"    </a>",
"    ]. The vast majority of these cases contain t(15;17)(q24.1;q21.1), although several variant translocations involving RARa have been identified, including t(11;17) and t(5;17) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Distinguishing between these translocations is important because patients with the variant translocation t(11;17) are almost invariably resistant to ATRA [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/3,4,6\">",
"     3,4,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/12/200?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The molecular biology of APL will be discussed here. The molecular biology of acute myeloid leukemias other than APL and of ALL is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/33/35354?source=see_link\">",
"     \"Pathogenesis of acute myeloid leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/25/22938?source=see_link\">",
"     \"Cytogenetics in acute lymphoblastic leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25882?source=see_link\">",
"     \"Molecular genetics of acute myeloid leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RETINOIC ACID AND THE RETINOIC ACID RECEPTOR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retinoic acid is a critical ligand in the differentiation pathway of multiple tissues, mediated through binding to a retinoic acid receptor (RAR). RARs belong to the nuclear",
"    <span class=\"nowrap\">",
"     steroid/thyroid",
"    </span>",
"    hormone receptor superfamily, and possess a modular structure with discrete ligand binding and DNA binding domains. Of the three isoforms of RARs, RARalpha (RARa) is expressed primarily in hematopoietic cells.",
"   </p>",
"   <p>",
"    RARa is a member of a family of retinoid-binding transcription factors (including RXR) that regulate gene expression. RARa contains a series of discrete functional domains, including an amino terminal transcriptional activation domain, followed by DNA-binding, dimerization, and retinoid-binding domains. RARa heterodimerizes with retinoid X receptor (RXR), and binds to retinoic acid responsive elements to regulate transcription of target genes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of retinoic acid,",
"    <span class=\"nowrap\">",
"     RARa/RXR-alpha",
"    </span>",
"    heterodimers interact with N-CoR (nuclear corepressor), a ubiquitous nuclear protein which mediates transcriptional repression [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/3,7\">",
"     3,7",
"    </a>",
"    ]. Retinoic acid dissociates N-CoR from",
"    <span class=\"nowrap\">",
"     RARa/RXR-alpha,",
"    </span>",
"    resulting in relief from transcriptional repression, presumably activating genes that lead to terminal differentiation of promyelocytes (",
"    <a class=\"graphic graphic_picture graphicRef76618 graphicRef66640 \" href=\"UTD.htm?24/39/25205\">",
"     picture 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The capacity of retinoids to induce myeloid differentiation was recognized prior to the identification of the involvement of RARa in APL. Retinoic acid had been shown to enhance the growth of normal myeloid progenitors, to induce differentiation of the HL-60 promyelocytic cell line, and to induce terminal differentiation of primary human APL cells cultured in vitro [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Subsequently, the use of all-trans retinoic acid (ATRA) was found to induce complete remissions in patients with APL. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28858?source=see_link\">",
"     \"Initial treatment of acute promyelocytic leukemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rather than inducing cell death from cytotoxicity, ATRA induces differentiation of the malignant promyelocytic clone, an effect which can be observed in vitro and in vivo [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. The effect in retinoic acid-sensitive NB4 cells in vivo is complex [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/15\">",
"     15",
"    </a>",
"    ], with ATRA modulating 169 genes in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/13\">",
"     13",
"    </a>",
"    ]. Although complete remission can be obtained with ATRA alone, most patients will ultimately relapse without additional cytotoxic chemotherapy. The basis for development of ATRA resistance remains unclear, but this phenomenon suggests that additional genetic events might occur in APL cells that confer resistance. The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/47/16119?source=see_link\">",
"     arsenic trioxide",
"    </a>",
"    has also been shown to induce remissions in APL, possibly by inducing the degradation of",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/37/12888?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment of relapsed or refractory acute promyelocytic leukemia in adults\", section on 'Arsenic trioxide'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     t(15;17) THE USUAL TRANSLOCATION IN APL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The leukemic cells of approximately 92 percent of patients with APL have the balanced translocation t(15;17)(q24.1;q21.1) involving the retinoic acid receptor-alpha (RAR-alpha, RARa) gene on chromosome 17 and the PML gene on chromosome 15 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. An additional 5 percent do not have the classic t(15;17), but have the",
"    <span class=\"nowrap\">",
"     PML/RARalpha",
"    </span>",
"    fusion gene, due to insertions or other complex chromosomal rearrangements [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     The PML gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ProMyelocytic Leukemia (PML) gene was first identified through its involvement with RARa in t(15;17) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. It is expressed ubiquitously, and multiple alternative splice variants have been isolated. The normal function of PML is not known, but overexpression of PML inhibits growth in cell lines, perhaps through the interferon-gamma signaling pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/20\">",
"     20",
"    </a>",
"    ]. Several studies have suggested the following properties for the gene [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is critical for the proper localization of all other ND10-associated proteins under physiological conditions",
"     </li>",
"     <li>",
"      It encodes a growth- and tumor-suppressor protein that is essential for several apoptotic signals",
"     </li>",
"     <li>",
"      It acts as a transcriptional co-activator with p53, the tumor suppressor gene",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The product of the PML gene is a nuclear protein that contains motifs suggestive of a role in control of RNA transcription, including two putative amino terminal DNA-binding domains and a potential dimerization domain. It is normally expressed in myeloid progenitors, and has been shown to localize to a discrete subnuclear compartment of unknown function, referred to as the nuclear body [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nuclear body is a novel nuclear structure referred to by several names, including PODs (PML oncogenic domains), or ND10 (nuclear domain 10) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. In APL cells, the integrity of the nuclear body is disrupted, and a microspeckled distribution of",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    is observed. Treatment of APL cells with ATRA causes the nuclear bodies to be regenerated with proper relocalization of PML.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/47/16119?source=see_link\">",
"     Arsenic trioxide",
"    </a>",
"    has also been found to target PML and",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    to nuclear bodies and to induce their degradation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/26\">",
"     26",
"    </a>",
"    ]. Thus, restoration of nuclear body structures by either ATRA or arsenic trioxide correlates with the ability of these agents to induce remission of APL.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     The fusion genes of t(15;17)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two novel fusion genes are formed as a result of the t(15;17): a",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    gene on the der(15) chromosome and an",
"    <span class=\"nowrap\">",
"     RARa/PML",
"    </span>",
"    gene on the der(17) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Whereas the",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    fusion gene is found consistently in all cases of t(15;17), the reciprocal",
"    <span class=\"nowrap\">",
"     RARa/PML",
"    </span>",
"    fusion can be detected in only 80 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/27\">",
"     27",
"    </a>",
"    ], due in some cases to loss of the der(17) chromosome. Although this suggests that the",
"    <span class=\"nowrap\">",
"     RARa/PML",
"    </span>",
"    fusion may not be essential in the pathogenesis of APL, its expression has been postulated to represent a potential second genetic event contributing to the leukemic phenotype.",
"   </p>",
"   <p>",
"    The resulting fusion gene on der(15) encodes a fusion protein in which the DNA-binding and dimerization domains of PML are fused to the DNA-binding and C-terminal portions of RAR-alpha, including the retinoid binding site. Breakpoints in RARa typically occur within intron 2, whereas breakpoints in PML are more heterogeneous, occurring within intron 3, intron 6, or exon 6, producing what has been called short, long, and variable forms [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The three different isoforms have somewhat different clinical characteristics; lack of sufficient numbers of patients with the less common variable form has made it difficult to determine whether the three isoforms have similar clinical outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/28-30\">",
"     28-30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Mechanism of action of PML/RARa",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    protein functions as an aberrant retinoid receptor that possesses altered DNA binding and transcriptional regulatory properties [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    can heterodimerize with RXR and bind to retinoic acid responsive elements in target genes. Expression of",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    blocks retinoic acid induced myeloid differentiation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition,",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    can block RARa mediated transactivation in a dominant negative manner. This dominant negative effect on normal RARa mediated functions is supported by experiments where a dominant negative mutation of RARa was introduced into a murine hematopoietic cell line [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/34\">",
"     34",
"    </a>",
"    ]. A block in differentiation along the neutrophil and monocytic lineages was observed, and a switch to the development of mast cells and basophils occurred.",
"   </p>",
"   <p>",
"    Experiments in transgenic mice demonstrated that expression of",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    in immature myeloid cells resulted in the development of a leukemia with promyelocytic features, thereby demonstrating the leukemogenic potential of the fusion protein [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/35\">",
"     35",
"    </a>",
"    ]. Expression of a",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    variant that is unable to activate transcription in response to retinoic acid also leads to leukemia; however, the leukemia does not differentiate in response to retinoic acid [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/36\">",
"     36",
"    </a>",
"    ]. Several groups have generated transgenic mice expressing",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    under the control of various myeloid-specific promoters. The phenotype in these mice depended on the stage of myeloid differentiation where the transgene was expressed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In mice with the transgene expressed under the control of the human MRP8 promoter, which drives expression in early myeloid progenitors as well as in mature neutrophils and monocytes, neutrophil numbers were normal, but differentiation was impaired. Approximately 30 percent developed acute leukemia with a latency of three to nine months; remission of the leukemia could be induced by ATRA [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Two groups have generated transgenic mice expressing",
"      <span class=\"nowrap\">",
"       PML/RARa",
"      </span>",
"      under the control of the human cathepsin G promoter, which drives expression in promonocytes and promyelocytes. These mice develop elevated numbers of immature myeloid cells in the bone marrow and peripheral blood. Approximately 10 to 30 percent develop leukemia with a latency of 12 to 14 months [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]. Treatment of these mice with ATRA caused apoptosis of myeloid precursors rather than differentiation.",
"     </li>",
"     <li>",
"      Transgenic mice expressing PML-RARa under the control of the CD11b promoter have also been generated [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/39\">",
"       39",
"      </a>",
"      ]. This promoter drives expression in later stages of myeloid differentiation. These mice do not develop leukemia and have normal numbers and maturation of myeloid cells. However, the ability of these mice to regenerate granulocytes following sublethal irradiation was impaired.",
"     </li>",
"     <li>",
"      Transgenic mice expressing PML-RARa in the setting of PML haploinsufficiency demonstrate a preferential expansion of PML-RARa expressing cells suggesting that this transgene supports self-renewal [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/40\">",
"       40",
"      </a>",
"      ]. This study showed that PML-RARa can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Comparison of the phenotypes observed in the different transgenic mice reveals that the timing of PML-RARa expression during myeloid differentiation is a critical determinant in the development of leukemia. In addition, the relatively low frequency and long latency period for development of leukemia imply that genetic events in addition to the expression of PML-RARa are necessary in order for APL to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The precise way in which the fusion protein functions as an oncoprotein is incompletely understood. The two isoforms,",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     RARa/PML,",
"    </span>",
"    have only subtle differences in function [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/43\">",
"     43",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    shows reduced sensitivity to retinoic acid in terms of dissociation of N-CoR [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/7\">",
"     7",
"    </a>",
"    ]. This could lead to persistent transcriptional repression, thereby preventing differentiation of promyelocytes. Pharmacologic concentrations of retinoic acid, as used in the treatment of APL, result in dissociation of N-CoR, presumably permitting differentiation of the leukemic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The binding of the protein product of",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    is thought to repress gene transcription through epigenomic changes including histone deacetylation or methylation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. One theory holds that",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    creates homodimers that interact with histone methyltransferase, DNA methyltransferase, and histone deacetylases that act as corepressors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/45\">",
"     45",
"    </a>",
"    ]. Together, they bind and repress the expression of differentiation genes thereby blocking differentiation at the promyelocyte stage (",
"    <a class=\"graphic graphic_figure graphicRef64089 \" href=\"UTD.htm?40/18/41255\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A mechanism which includes the recruitment of a histone deacetylase may have therapeutic implications because in vitro studies have shown that resistance to all-trans retinoic acid can be overcome by the addition of a histone deacetylase inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. In addition, case reports and small trials have reported clinical responses to histone deacetylase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    also may prolong the survival of the leukemic cells, perhaps in part by leading to downregulation of tumor necrosis factor-alpha (TNFa) receptors, thereby minimizing TNFa-induced apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/50\">",
"     50",
"    </a>",
"    ]. On the other hand,",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    in the presence of retinoic acid induces apoptosis in association with reduced levels of BCL-2 which normally protects against apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In support of this hypothesis are results obtained with mouse [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/51\">",
"     51",
"    </a>",
"    ] and human [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/52\">",
"     52",
"    </a>",
"    ] multipotent hematopoietic progenitor",
"    <span class=\"nowrap\">",
"     cells/stem",
"    </span>",
"    cells",
"    <span class=\"nowrap\">",
"     (HPC/HSC)",
"    </span>",
"    transfected in vitro with a retroviral vector containing",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    cDNA. Expression of the",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    fusion protein in human cells dictated the APL phenotype through the following effects [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/52\">",
"     52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rapid induction of human",
"      <span class=\"nowrap\">",
"       HPC/HSC",
"      </span>",
"      differentiation to the promyelocytic stage",
"     </li>",
"     <li>",
"      Maturation arrest at the promyelocytic stage, which was abolished by retinoic acid",
"     </li>",
"     <li>",
"      Reprogramming of HPC commitment to preferential granulopoietic differentiation irrespective of the hematopoietic growth factor (HGF) stimulus",
"     </li>",
"     <li>",
"      Protection of HPC from apoptosis induced by HGF deprivation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further mouse studies have demonstrated that expression of",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    supports the immortalization of clonogenic myeloid progenitors also known as leukemia-initiating cells (LICs) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/45,53\">",
"     45,53",
"    </a>",
"    ]. The degradation of",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    by retinoic acid triggers the loss of these cells. The destruction of LICs, which are immune to the differentiation effects of retinoic acid, appears to be a key factor in the eradication of APL.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     VARIANT TRANSLOCATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of variant translocations have been described in APL, with t(11;17)(q23;q21.1), t(5;17)(q35;q21.1), and t(11;17)(q13;q21.1) being the most common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     PLZF/RARa and t(11;17)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variant translocation t(11;17)(q23;q21.1) has been described in approximately 1 percent of patients with APL [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/17,54\">",
"     17,54",
"    </a>",
"    ]. In these tumors, the 3' end of the RARa gene is fused to the 5' end of a gene called PLZF (promyelocytic leukemia zinc finger), which encodes a polypeptide containing nine zinc fingers, a motif frequently found in transcription factors. PLZF is expressed in myeloid but not lymphoid lineages, and its expression has been found to be downregulated during differentiation. Unlike PML, PLZF is not a component of nuclear bodies, but is localized in smaller, more numerous nuclear subdomains.",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     PLZF/RARa",
"    </span>",
"    fusion gene is predicted to encode a protein consisting of the amino terminal portion of PLZF, including several zinc fingers, and the same carboxy terminal portion of RARa that is fused to PML in cells having t(15;17). The",
"    <span class=\"nowrap\">",
"     PLZF/RARa",
"    </span>",
"    fusion protein antagonizes the normal function of",
"    <span class=\"nowrap\">",
"     RARa/RXR-alpha",
"    </span>",
"    heterodimers, suggesting that it behaves as a dominant negative mutant [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the number of cases studied is small, APL with t(11;17)(q23;q21.1) is usually",
"    <strong>",
"     refractory to therapy with retinoids",
"    </strong>",
"    , in contrast to the great majority of APL cases with the more common t(15;17) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/3,56\">",
"     3,56",
"    </a>",
"    ]. As noted above,",
"    <span class=\"nowrap\">",
"     PML/RARa",
"    </span>",
"    in t(15;17) shows reduced sensitivity to retinoic acid, but this can be overcome by pharmacological concentrations of retinoic acid. In contrast, pharmacological concentrations of retinoic acid do not induce dissociation of N-CoR from",
"    <span class=\"nowrap\">",
"     PLZF/RARa,",
"    </span>",
"    leading to persistent transcription repression and prevention of differentiation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/7,57\">",
"     7,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     NPM/RARa and t(5;17)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rare (less than 0.5 percent) variant translocation in APL has been described, t(5;17)(q35;q21.1), in which the nucleophosmin (NPM) gene was fused to RARa [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/17,58\">",
"     17,58",
"    </a>",
"    ]. NPM is a nucleolar phosphoprotein that is involved in ribosomal ribonucleoprotein processing and transport. NPM is also involved in the t(2;5)(p23;q35) in anaplastic large cell lymphoma, where it fuses to the ALK gene. In addition, NPM has been found to fuse to the MLF1 gene in t(3;5)(q25.1;q35) in AML. Patients with this translocation are",
"    <strong>",
"     responsive to ATRA therapy",
"    </strong>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     NuMA/RARa and t(11;17)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the translocation t(11;17)(q13;q21.1), the Nuclear matrix-mitotic apparatus protein gene (NuMA) is fused with RARa [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/6\">",
"     6",
"    </a>",
"    ]. Unlike t(11;17)(q23;q21.1), this variant appears",
"    <strong>",
"     responsive to ATRA",
"    </strong>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     STAT5b/RARa and interstitial chromosome 17 deletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rare fusion between STAT5b (signal transducer and activator of transcription 5b) and RARa was found in a patient with an interstitial chromosome 17 deletion and an",
"    <strong>",
"     ATRA-resistant",
"    </strong>",
"    form of APL [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/60-62\">",
"     60-62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H175775309\">",
"    <span class=\"h2\">",
"     BCOR/RARa and t(X;17)(q11;q21.1)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A case of APL demonstrating rectangular and round cytoplasmic inclusion bodies was found to have the translocation t(X;17)(q11;q21.1) resulting in a fusion between the BCL6 corepressor gene (BCOR) and RARa [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17976/abstract/63\">",
"     63",
"    </a>",
"    ]. While this case was clinically responsive to ATRA, the patient had several episodes of relapse with standard chemotherapy plus ATRA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H358657\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute promyelocytic leukemia (APL) is a biologically and clinically distinct variant of acute myeloid leukemia (AML) characterized by a translocation involving the retinoic acid receptor-alpha (RARa) locus on chromosome 17.",
"     </li>",
"     <li>",
"      RARa is a nuclear",
"      <span class=\"nowrap\">",
"       steroid/thyroid",
"      </span>",
"      hormone receptor that is expressed primarily in hematopoietic cells. RARa heterodimerizes with retinoid X receptor (RXR).",
"      <span class=\"nowrap\">",
"       RARa/RXR-alpha",
"      </span>",
"      heterodimers interact with N-CoR (nuclear corepressor), a ubiquitous nuclear protein which mediates transcriptional repression and presumable prevents the terminal differentiation of promyelocytes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Retinoic acid and the retinoic acid receptor'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The leukemic cells of approximately 92 percent of patients with APL have the balanced translocation t(15;17)(q24.1;q21.1) involving the RARa gene on chromosome 17 and the ProMyelocytic Leukemia (PML) gene on chromosome 15. An additional 5 percent do not have the classic t(15;17), but have the",
"      <span class=\"nowrap\">",
"       PML/RARalpha",
"      </span>",
"      fusion gene, due to insertions or other complex chromosomal rearrangements. (See",
"      <a class=\"local\" href=\"#H3\">",
"       't(15;17) the usual translocation in APL'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The PML gene is expressed ubiquitously and the normal function is not known. Overexpression of PML inhibits growth in cell lines. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'The PML gene'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two novel fusion genes are formed as a result of the t(15;17) (see",
"      <a class=\"local\" href=\"#H5\">",
"       'The fusion genes of t(15;17)'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A",
"      <span class=\"nowrap\">",
"       PML/RARa",
"      </span>",
"      gene on the der(15) chromosome found in all cases. The resulting fusion gene encodes a fusion protein in which the DNA-binding and dimerization domains of PML are fused to the DNA-binding and C-terminal portions of RAR-alpha, including the retinoid binding site.",
"     </li>",
"     <li>",
"      An",
"      <span class=\"nowrap\">",
"       RARa/PML",
"      </span>",
"      gene on the der(17) can be detected in 80 percent of cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <span class=\"nowrap\">",
"       PML/RARa",
"      </span>",
"      protein functions as an aberrant retinoid receptor expression of which blocks retinoic acid induced myeloid differentiation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Mechanism of action of PML/RARa'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of variant translocations have been described in APL with therapeutic implications (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Variant translocations'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      t(11;17)(q23;q21.1) seen in approximately 1 percent of patients with APL results in the fusion of the RARa gene with the PLZF (promyelocytic leukemia zinc finger) gene, which is expressed in myeloid but not lymphoid lineages. APL with t(11;17)(q23;q11.12) is usually",
"      <strong>",
"       refractory to therapy with retinoids",
"      </strong>",
"      .",
"     </li>",
"     <li>",
"      t(5;17)(q35;q21.1) is seen in less than 0.5 percent and results in the fusion of the nucleophosmin (NPM) gene to RARa. Patients with this translocation are",
"      <strong>",
"       responsive to ATRA therapy",
"      </strong>",
"      .",
"     </li>",
"     <li>",
"      t(11;17)(q13;q21.1) results in the fusion of the nuclear matrix-mitotic apparatus protein gene (NuMA) and RARa. This variant appears",
"      <strong>",
"       responsive to ATRA.",
"      </strong>",
"      &nbsp;",
"     </li>",
"     <li>",
"      A rare fusion between STAT5b and RARa was found in a patient with an interstitial chromosome 17 deletion and an",
"      <strong>",
"       ATRA-resistant",
"      </strong>",
"      form of APL.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Swerdlow SH, Campo E, Harris NL, et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/2\">",
"      de Th&eacute; H, Chomienne C, Lanotte M, et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/3\">",
"      Collins SJ. Acute promyelocytic leukemia: relieving repression induces remission. Blood 1998; 91:2631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/4\">",
"      Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93:3167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/5\">",
"      Grimwade D. The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. Br J Haematol 1999; 106:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/6\">",
"      Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994; 83:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/7\">",
"      Guidez F, Ivins S, Zhu J, et al. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 1998; 91:2634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/8\">",
"      Mueller BU, Pabst T, Fos J, et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 2006; 107:3330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/9\">",
"      Breitman TR, Collins SJ, Keene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/10\">",
"      Robertson KA, Emami B, Mueller L, Collins SJ. Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Mol Cell Biol 1992; 12:3743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/11\">",
"      Gratas C, Menot ML, Dresch C, Chomienne C. Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 1993; 7:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/12\">",
"      Warrell RP Jr, de Th&eacute; H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/13\">",
"      Liu TX, Zhang JW, Tao J, et al. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 2000; 96:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/14\">",
"      Cassinat B, Chevret S, Zassadowski F, et al. In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. Blood 2001; 98:2862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/15\">",
"      Altucci L, Rossin A, Raffelsberger W, et al. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 2001; 7:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/16\">",
"      Nasr R, Lallemand-Breitenbach V, Zhu J, et al. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure. Clin Cancer Res 2009; 15:6321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/17\">",
"      Grimwade D, Biondi A, Mozziconacci MJ, et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Fran&ccedil;ais de Cytog&eacute;n&eacute;tique H&eacute;matologique, Groupe de Fran&ccedil;ais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action \"Molecular Cytogenetic Diagnosis in Haematological Malignancies\". Blood 2000; 96:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/18\">",
"      de Th&eacute; H, Lavau C, Marchio A, et al. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/19\">",
"      Kakizuka A, Miller WH Jr, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/20\">",
"      Choi YH, Bernardi R, Pandolfi PP, Benveniste EN. The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling. Proc Natl Acad Sci U S A 2006; 103:18715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/21\">",
"      Maul GG, Negorev D, Bell P, Ishov AM. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J Struct Biol 2000; 129:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/22\">",
"      Guo A, Salomoni P, Luo J, et al. The function of PML in p53-dependent apoptosis. Nat Cell Biol 2000; 2:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/23\">",
"      Zhong S, Salomoni P, Ronchetti S, et al. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J Exp Med 2000; 191:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/24\">",
"      Weis K, Rambaud S, Lavau C, et al. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 1994; 76:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/25\">",
"      Dyck JA, Maul GG, Miller WH Jr, et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994; 76:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/26\">",
"      Zhu J, Koken MH, Quignon F, et al. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci U S A 1997; 94:3978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/27\">",
"      Goddard AD, Borrow J, Freemont PS, Solomon E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 1991; 254:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/28\">",
"      Gallagher RE, Willman CL, Slack JL, et al. Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study. Blood 1997; 90:1656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/29\">",
"      Slack JL, Willman CL, Andersen JW, et al. Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129. Blood 2000; 95:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/30\">",
"      Gonz&aacute;lez M, Barrag&aacute;n E, Bolufer P, et al. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group. Br J Haematol 2001; 114:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/31\">",
"      Perez A, Kastner P, Sethi S, et al. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 1993; 12:3171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/32\">",
"      C&ocirc;t&eacute; S, Zhou D, Bianchini A, et al. Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia. Blood 2000; 96:3200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/33\">",
"      Grignani F, Ferrucci PF, Testa U, et al. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993; 74:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/34\">",
"      Tsai S, Bartelmez S, Heyman R, et al. A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 1992; 6:2258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/35\">",
"      Brown D, Kogan S, Lagasse E, et al. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci U S A 1997; 94:2551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/36\">",
"      Kogan SC, Hong SH, Shultz DB, et al. Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood 2000; 95:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/37\">",
"      Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood 1997; 89:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/38\">",
"      He LZ, Tribioli C, Rivi R, et al. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A 1997; 94:5302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/39\">",
"      Early E, Moore MA, Kakizuka A, et al. Transgenic expression of PML/RARalpha impairs myelopoiesis. Proc Natl Acad Sci U S A 1996; 93:7900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/40\">",
"      Welch JS, Yuan W, Ley TJ. PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice. J Clin Invest 2011; 121:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/41\">",
"      Kogan SC, Brown DE, Shultz DB, et al. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia. J Exp Med 2001; 193:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/42\">",
"      Le Beau MM, Bitts S, Davis EM, Kogan SC. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. Blood 2002; 99:2985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/43\">",
"      Slack JL, Yu M. Constitutive expression of the promyelocytic leukemia-associated oncogene PML-RARalpha in TF1 cells: isoform-specific and retinoic acid-dependent effects on growth, bcl-2 expression, and apoptosis. Blood 1998; 91:3347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/44\">",
"      Hoemme C, Peerzada A, Behre G, et al. Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip. Blood 2008; 111:2887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/45\">",
"      Licht JD. Acute promyelocytic leukemia--weapons of mass differentiation. N Engl J Med 2009; 360:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/46\">",
"      Lin RJ, Nagy L, Inoue S, et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 1998; 391:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/47\">",
"      Grignani F, De Matteis S, Nervi C, et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/48\">",
"      Warrell RP Jr, He LZ, Richon V, et al. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 1998; 90:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/49\">",
"      Bug G, Ritter M, Wassmann B, et al. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia. Cancer 2005; 104:2717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/50\">",
"      Testa U, Grignani F, Samoggia P, et al. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts. J Clin Invest 1998; 101:2278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/51\">",
"      Minucci S, Monestiroli S, Giavara S, et al. PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors. Blood 2002; 100:2989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/52\">",
"      Grignani F, Valtieri M, Gabbianelli M, et al. PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. Blood 2000; 96:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/53\">",
"      Nasr R, Guillemin MC, Ferhi O, et al. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat Med 2008; 14:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/54\">",
"      Chen Z, Brand NJ, Chen A, et al. Fusion between a novel Kr&uuml;ppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 1993; 12:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/55\">",
"      Chen Z, Guidez F, Rousselot P, et al. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci U S A 1994; 91:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/56\">",
"      Guidez F, Huang W, Tong JH, et al. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient. Leukemia 1994; 8:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/57\">",
"      Licht JD, Chomienne C, Goy A, et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 1995; 85:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/58\">",
"      Redner RL, Rush EA, Faas S, et al. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 1996; 87:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/59\">",
"      Wells RA, Hummel JL, De Koven A, et al. A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation. Leukemia 1996; 10:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/60\">",
"      Arnould C, Philippe C, Bourdon V, et al. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Hum Mol Genet 1999; 8:1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/61\">",
"      Dong S, Tweardy DJ. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways. Blood 2002; 99:2637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/62\">",
"      Collins SJ. Acute promyelocytic leukemia: STATs, HATs, and HDACs. Blood 2002; 99:2635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17976/abstract/63\">",
"      Yamamoto Y, Tsuzuki S, Tsuzuki M, et al. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Blood 2010; 116:4274.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4523 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-D795AC79FE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17976=[""].join("\n");
var outline_f17_35_17976=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H358657\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RETINOIC ACID AND THE RETINOIC ACID RECEPTOR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      t(15;17) THE USUAL TRANSLOCATION IN APL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      The PML gene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      The fusion genes of t(15;17)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Mechanism of action of PML/RARa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      VARIANT TRANSLOCATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PLZF/RARa and t(11;17)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      NPM/RARa and t(5;17)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      NuMA/RARa and t(11;17)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      STAT5b/RARa and interstitial chromosome 17 deletion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H175775309\">",
"      BCOR/RARa and t(X;17)(q11;q21.1)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H358657\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4523\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4523|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/18/41255\" title=\"figure 1\">",
"      PML-RARa action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4523|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/21/33119\" title=\"picture 1A\">",
"      APL hypergranular variant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/31/26097\" title=\"picture 1B\">",
"      Tretinoin APL differentiation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39720?source=related_link\">",
"      Classification of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/12/200?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/25/22938?source=related_link\">",
"      Cytogenetics in acute lymphoblastic leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28858?source=related_link\">",
"      Initial treatment of acute promyelocytic leukemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25882?source=related_link\">",
"      Molecular genetics of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/33/35354?source=related_link\">",
"      Pathogenesis of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/37/12888?source=related_link\">",
"      Treatment of relapsed or refractory acute promyelocytic leukemia in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_35_17977="Basic principles and technique of cardioversion and defibrillation";
var content_f17_35_17977=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Basic principles and technique of cardioversion and defibrillation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17977/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17977/contributors\">",
"     Bradley P Knight, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17977/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17977/contributors\">",
"     Richard L Page, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/35/17977/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/35/17977/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/35/17977/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrical cardioversion and defibrillation have become routine procedures in the management of patients with cardiac arrhythmias. Cardioversion is the delivery of energy that is synchronized to the QRS complex, while defibrillation is the nonsynchronized delivery of a shock randomly during the cardiac cycle. In 1956, alternating current (AC) for transthoracic defibrillation was first used to treat ventricular fibrillation in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/1\">",
"     1",
"    </a>",
"    ]. Following this breakthrough, in 1962 direct current (DC) defibrillators were introduced into clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/2\">",
"     2",
"    </a>",
"    ]. Subsequent studies in the early 1960s demonstrated that electrical countershock or cardioversion across the closed chest could abolish other cardiac arrhythmias in addition to ventricular fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most defibrillators are energy-based, meaning that the devices charge a capacitor to a selected voltage and then deliver a prespecified amount of energy in joules. The amount of energy which arrives at the myocardium is dependent upon the selected voltage and the transthoracic impedance (which varies by patient).",
"   </p>",
"   <p>",
"    Two other types of defibrillators are used less frequently in clinical practice:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Impedance-based defibrillators allow selection of transthoracic current based upon the transthoracic impedance; the latter is assessed initially with a test pulse with the capacitor subsequently charged to the appropriate voltage [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Current-based defibrillation, in which a fixed dose of current is delivered, results in defibrillation thresholds that are independent of transthoracic impedance and are invariant for the individual [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. Defibrillation success for a current-based method is independent of both transthoracic impedance and body weight [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/9\">",
"       9",
"      </a>",
"      ]. Furthermore, this method achieves defibrillation with considerably less energy than does the conventional energy-based method.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Defibrillators can also deliver energy in a variety of waveforms, broadly characterized as monophasic or biphasic (",
"    <a class=\"graphic graphic_figure graphicRef51842 \" href=\"UTD.htm?23/36/24140\">",
"     figure 1",
"    </a>",
"    ). Initially defibrillators delivered only monophasic waveforms. Although monophasic defibrillation is highly effective, biphasic defibrillation terminates arrhythmias more consistently and at lower energy levels. While many monophasic defibrillators remain in use, biphasic defibrillators are becoming increasingly popular. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Monophasic versus biphasic waveforms'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    This topic will review the basic principles and technique of electrical cardioversion and defibrillation. The clinical indications for these procedures, procedural sedation, potential side effects, and the use of the automated external defibrillator (AED) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11050?source=see_link\">",
"     \"Cardioversion for specific arrhythmias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34618?source=see_link\">",
"     \"Procedural sedation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25208?source=see_link\">",
"     \"Automated external defibrillators\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ELECTROPHYSIOLOGY OF DEFIBRILLATION AND CARDIOVERSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardioversion terminates arrhythmias by delivering a synchronized shock that depolarizes the tissue involved in a reentrant circuit (",
"    <a class=\"graphic graphic_figure graphicRef52134 \" href=\"UTD.htm?9/50/10017\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef82249 \" href=\"UTD.htm?38/33/39441\">",
"     figure 3",
"    </a>",
"    ). By depolarizing all excitable tissue of the circuit and making the tissue refractory, the circuit is no longer able to propagate or sustain reentry. As a result, cardioversion terminates those arrhythmias resulting from a single reentrant circuit, such as atrial flutter, atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, or monomorphic ventricular tachycardia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/62/42984?source=see_link\">",
"     \"Reentry and the development of cardiac arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite its widespread clinical use, controversy remains concerning the electrophysiologic mechanisms by which electrical cardioversion or defibrillation terminates atrial or ventricular fibrillation, arrhythmias which involve multiple microreentrant circuits. Fibrillation involves the entire atrial or ventricular myocardium and is considered to be a very persistent rhythm. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=see_link\">",
"     \"The electrocardiogram in atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathophysiology and etiology of sudden cardiac arrest\", section on 'Mechanism of VF'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most investigators agree that defibrillation occurs when a certain amount of current density reaches the myocardium. However, it is unclear what amount of current density is needed and what energy setting is necessary to achieve a homogeneous current density. At the cellular level, the delivered current flows around and through the myocardial cells, resulting in alteration of the transmembrane potentials [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/10\">",
"     10",
"    </a>",
"    ]. At the organ level, the mechanisms responsible for termination of fibrillation are still controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/11\">",
"     11",
"    </a>",
"    ]. Two explanations have been proposed, which are not necessarily mutually exclusive: the critical mass hypothesis and the upper limit of vulnerability.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Critical mass hypothesis &mdash; There is general agreement that total elimination of fibrillatory activity can be achieved with relatively high defibrillation energy levels [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. According to the critical mass hypothesis, a certain amount of myocardium must be available to sustain atrial or ventricular fibrillation and the entire myocardium must be uniformly depolarized in order to terminate the arrhythmia [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/14\">",
"       14",
"      </a>",
"      ]. Electrophysiological evidence to support this theory has been obtained using a computerized mapping system that recorded simultaneous electrograms from 120 sites [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/12\">",
"       12",
"      </a>",
"      ]. Defibrillation was successful only when fibrillatory activity was annihilated at all sites.",
"     </li>",
"     <li>",
"      Upper limit of vulnerability hypothesis &mdash; According to the upper limit of vulnerability hypothesis, unsuccessful shocks are slightly weaker than necessary for defibrillation [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/15\">",
"       15",
"      </a>",
"      ]. Although they abolish small areas of localized reentry during ventricular fibrillation, they stimulate other regions of myocardium during their vulnerable period, giving rise to new areas of local reentry that reinitiate ventricular fibrillation [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/16-18\">",
"       16-18",
"      </a>",
"      ]. To successfully defibrillate, therefore, the shock strength must be greater than the largest shock that reinitiates fibrillation (the upper limit of vulnerability). This hypothesis is supported by the observation that almost identical changes in the upper limit of vulnerability and the defibrillation threshold occur with changes in electrode polarity and waveform duration [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Transcardiac shocks of up to 30 joules were delivered to canine myocardial tissue at different times of the cardiac cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/20\">",
"     20",
"    </a>",
"    ]. A shock applied 10 milliseconds (msec) before the end of the refractory period extended the refractory period by 63 msec, whereas the same shock given 40 msec earlier produced only a 25 msec increase in the refractory period. In contrast, a five-joule shock applied at the same times during the cardiac cycle produced only a 36 and 10 msec increase in the refractory period, respectively.",
"   </p>",
"   <p>",
"    Because the higher intensity shock selectively extends the refractory period of the myocardium, it may establish a zone of tissue in which repolarization is delayed. This zone is always immediately in front of the newly depolarized tissue, and the inability of the depolarizing impulse to propagate across these refractory zones may be the mechanism responsible for terminating fibrillation. The size of these zones and the duration of increased refractoriness both increase with increasing shock intensity; this may account for the relatively high shock energies required for defibrillation relative to the intensities required to directly depolarize the tissue.",
"   </p>",
"   <p>",
"    An electrical shock will also induce different degrees of action potential duration prolongation and dispersion of ventricular repolarization, depending upon shock strength and timing [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/21\">",
"     21",
"    </a>",
"    ]. One study, performed during the post-implantation testing of implantable cardioverter-defibrillators, found that shocks delivered on the T wave generated variable degrees of action potential prolongation, depending upon myocardial repolarization [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/22\">",
"     22",
"    </a>",
"    ]. The creation of high dispersion of repolarization facilitated reentry by creating functional blocks and subsequently favored the induction of ventricular fibrillation and the prevention of its termination by a shock.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     FACTORS AFFECTING DEFIBRILLATION AND CARDIOVERSION SUCCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of device-related and patient-related factors will influence the chances of successful cardioversion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    defibrillation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2817474\">",
"    <span class=\"h2\">",
"     Device-related variables",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Electrodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of electrode characteristics can affect the outcome of cardioversion. These include electrode position, pad size, and hand-held versus patch electrodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h4\">",
"     Electrode position",
"    </span>",
"    &nbsp;&mdash;&nbsp;The placement of defibrillation electrodes on the thorax determines the transthoracic current pathway for external defibrillation. There are two conventional positions for electrode placement:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anterolateral orientation (",
"      <a class=\"graphic graphic_figure graphicRef58585 \" href=\"UTD.htm?10/13/10448\">",
"       figure 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Anteroposterior orientation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several studies have suggested that less energy is required and the success rate is higher with the anteroposterior electrode position in patients cardioverted for atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/23-26\">",
"     23-26",
"    </a>",
"    ]. As an example, in one study of 301 patients, sinus rhythm was restored in 87 percent using an anteroposterior position compared with 76 percent with an anterolateral orientation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/24\">",
"     24",
"    </a>",
"    ]. In the same study, the mean energy required for successful cardioversion was lower in patients with an anteroposterior electrode position (237 versus 287 joules) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, other reports have failed to confirm these findings and suggest that there is no clear advantage to either electrode configuration [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. In some patients one, but not the other position, may be effective. As a result, if initial attempts are unsuccessful in terminating the arrhythmia, the electrodes should be relocated to the other position and attempts at defibrillation or cardioversion repeated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Pad size",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrode pad size is an important determinant of transthoracic current flow during external countershock [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/27,30-32\">",
"     27,30-32",
"    </a>",
"    ]. One study analyzed the outcome of cardiac arrests in 105 patients using self-adhesive defibrillator pads of different sizes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/32\">",
"     32",
"    </a>",
"    ]. A single shock of 200 joules was successful in 31 percent of cardiac arrests using two small pads (each 8 cm in diameter), in 63 percent with one small and one large pad (8 and 12 cm in diameter), and in 82 percent when two large pads (each 12 cm in diameter) were used.",
"   </p>",
"   <p>",
"    A larger pad or paddle surface is associated with a decrease in resistance and increase in current and may cause less myocardial necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. However, there appears to be an optimal electrode size (approximately 12.8 cm) above which any further increase in electrode area causes a decline in current density [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h4\">",
"     Hand-held versus patch",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of hand-held paddle electrodes may be more effective than self-adhesive patch electrodes. This was illustrated in a randomized trial of 201 patients referred for cardioversion of persistent atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/37\">",
"     37",
"    </a>",
"    ]. Success rates were slightly higher for patients assigned to paddle electrodes (96 versus 88 percent with patch electrodes). Improved electrode-to-skin contact and reduced transthoracic impedance with hand-held electrodes may explain the benefit.",
"   </p>",
"   <p>",
"    However, there are no published data comparing hand-held paddle electrodes to self-adhesive patch electrodes for other arrhythmias requiring cardioversion (eg, atrioventricular nodal reentrant tachycardia, atrial flutter) or defibrillation (eg, ventricular fibrillation). Therefore, the decision to use hand-held or self-adhesive electrodes should be made based on the available equipment and the opinion of the operator regarding which electrodes are more likely to be effective for the patient at hand.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Monophasic versus biphasic waveforms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defibrillators can deliver energy in a variety of waveforms that are broadly characterized as monophasic or biphasic. Defibrillators developed prior to 2000 deliver a monophasic wave of direct electrical current. Since then, \"biphasic\" devices, which reverse current polarity 5 to 10 milliseconds after discharge begins, have been developed (",
"    <a class=\"graphic graphic_figure graphicRef51842 \" href=\"UTD.htm?23/36/24140\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Biphasic waveforms defibrillate more effectively and at lower energies than monophasic waveforms. This benefit has been demonstrated in both animals and humans, and with both ventricular and atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/38-47\">",
"     38-47",
"    </a>",
"    ]. However, monophasic defibrillation is still highly effective in most situations, and it is not clear that the superior efficacy of biphasic defibrillation results in important clinical advantages.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h4\">",
"     Ventricular fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several randomized trials have compared monophasic and biphasic waveforms in the treatment of ventricular fibrillation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Optimized Response to Cardiac Arrest (ORCA) trial, 115 patients with an out-of-hospital cardiac arrest due to ventricular fibrillation were randomly assigned to defibrillation using a 150 joule biphasic shock or traditional high-energy (200 to 360 joules) monophasic shocks [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/43\">",
"       43",
"      </a>",
"      ]. Successful defibrillation was significantly more likely with biphasic waveforms compared to monophasic waveforms after one shock and total treatment under Emergency Medical Services care (96 versus 59, and 100 versus 84 percent respectively). In addition, the rate of return of spontaneous circulation was higher with biphasic shock therapy (76 versus 54 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, there was no difference in the rate of survival to hospital discharge between the two therapies. Among patients who survived to discharge, those treated with a biphasic shock were more likely to have good cerebral performance (87 versus 53 percent).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Out-of-hospital cardiac arrest rectilinear biphasic to monophasic damped sine defibrillation waveforms with advanced life support intervention trial (ORBIT) of 169 patient with out-of-hospital cardiac arrest, biphasic shocks (escalating 120, 150, or 200 joules) were more effective than monophasic shocks (escalating 200, 300, and 360 joules) as defined by conversion at 5 sec to an organized rhythm (52 versus 34 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/48\">",
"       48",
"      </a>",
"      ]. However, there were no significant differences in return of spontaneous circulation (47 percent in both groups) or survival to discharge from hospital (9 versus 7 percent).",
"     </li>",
"     <li>",
"      In the Transthoracic Incremental Monophasic versus Biphasic defibrillation by Emergency Responders (TIMBER) trial, 168 patients with an out-of-hospital cardiac arrest due to ventricular fibrillation were randomly assigned to treatment with either monophasic or biphasic defibrillation [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/49\">",
"       49",
"      </a>",
"      ]. Defibrillation was initially performed by Emergency Medical Service with an automated external defibrillator (AED), and if necessary, with a manual defibrillator by paramedics who arrived later. Patients were included only if all shocks were delivered with the same waveform. In contrast to the ORCA trial, in TIMBER the defibrillation energies were the same for both waveforms (200 followed by 200 and then 360 joules).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There were no statistically significant differences between the treatment arms with regard to the success of initial shocks, the rate of survival, or neurologic outcomes. However, biphasic defibrillation did result in nonsignificant trends towards earlier return of spontaneous circulation and increased overall survival (41 versus 34 percent, compared to monophasic defibrillation).",
"   </p>",
"   <p>",
"    There is no clear explanation for the discrepant findings in these three trials. Due to the complexities and urgencies associated with resuscitation, in combination with the small sample sizes available for controlled studies, it is difficult to demonstrate or exclude important clinical benefits. Based upon the greater efficacy of biphasic defibrillation demonstrated in other settings, the lack of evidence of harm from biphasic defibrillation, and the trends towards outcome benefits suggested by clinical trials, we support the expanded use of biphasic defibrillation for the treatment of ventricular arrhythmias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h4\">",
"     Atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of the biphasic waveform for the treatment of atrial fibrillation (AF) has been illustrated in two randomized trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one trial, 174 patients with AF were randomly assigned to cardioversion with a monophasic waveform, using sequential shocks of 100 to 360 joules, or biphasic waveform, with energies of 70 to 170 joules [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/45\">",
"       45",
"      </a>",
"      ]. First shock efficacy was greater with a biphasic waveform (68 versus 21 percent), delivered energy was 50 percent less, and the overall cardioversion rate was higher (94 versus 79 percent).",
"     </li>",
"     <li>",
"      Similar benefits were noted in a comparable randomized trial of 210 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/46\">",
"       46",
"      </a>",
"      ]. Biphasic waveforms were associated with the following significant benefits: greater first shock efficacy (60 versus 22 percent); fewer total shocks (1.7 versus 2.8); less energy delivered (217 versus 548 joules), and a lower frequency of dermal injury (17 versus 41 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a larger nonrandomized experience, 2546 patients with AF were cardioverted using a monophasic (1996 to 1999) or biphasic (1999 to 2001) defibrillator [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/47\">",
"     47",
"    </a>",
"    ]. With the biphasic waveform, the overall success of cardioversion was greater (99.1 versus 92.4 percent) and the energy level required for cardioversion was lower (median 100 versus 200 joules).",
"   </p>",
"   <p>",
"    Similar findings have been reported for patients with atrial flutter, in whom cardioversion was successful more frequently and at lower energy levels when using biphasic waveforms [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h4\">",
"     Optimal biphasic defibrillation energies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because biphasic shocks are more effective at lower energies than monophasic shocks, initial protocols often suggested using lower-energy biphasic shocks during resuscitation (eg, 150 joules). The value of higher energy biphasic shocks was demonstrated in the BIPHASIC trial [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/52\">",
"     52",
"    </a>",
"    ]. A series of 221 patients with out-of-hospital cardiac arrest were randomly assigned to either fixed lower energy defibrillation (150 joules, followed by up to two additional shocks at the same energy as necessary), or to escalating higher-energy shocks (200 joules, followed by 300 and 360 joule shocks as necessary). Shocks were administered by an AED. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rate of successful defibrillation with the first shock was the same in both groups (37 versus 38 percent in the escalating higher and fixed lower treatment groups, respectively).",
"     </li>",
"     <li>",
"      Among patients requiring multiple shocks (n = 106), patients assigned to the escalating higher-energy protocol were significantly more likely to be successfully cardioverted (37 versus 25 percent, compared to patients assigned to the fixed lower-energy protocol).",
"     </li>",
"     <li>",
"      There were no significant differences between regimens in adverse events including cardiac enzyme elevation and left ventricular systolic dysfunction.",
"     </li>",
"     <li>",
"      There were no differences between regimens in survival outcomes, although this could be due in part to the relatively small sample size.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon the absence of adverse events and the greater efficacy in patients requiring multiple shocks, we agree with the use of escalating higher-energy shocks with biphasic defibrillators in the treatment of cardiac arrest due to a ventricular tachyarrhythmia that does not respond to an initial lower energy shock.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155703\">",
"    <span class=\"h2\">",
"     Patient-related variables",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Transthoracic impedance",
"    </span>",
"    &nbsp;&mdash;&nbsp;To compensate for transthoracic impedance during transthoracic defibrillation, a considerably larger current must be delivered to the thorax than is required for internal defibrillation. Impedance results in the dissipation of energy due to shunting to the lungs, the thoracic cage, and other elements of the chest. In an animal study, 82 percent of the transthoracic current was shunted to the thoracic cage, 14 percent to the lungs, and only 4 percent passed through to the heart [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transthoracic impedance is determined by multiple factors including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Energy level",
"     </li>",
"     <li>",
"      Electrode-to-skin interface",
"     </li>",
"     <li>",
"      Interelectrode distance",
"     </li>",
"     <li>",
"      Electrode pressure (with hand-held electrodes)",
"     </li>",
"     <li>",
"      Phase of ventilation",
"     </li>",
"     <li>",
"      Myocardial tissue and blood conductive properties",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In animals, repetitive shocks delivered at three minute intervals decrease the transthoracic impedance to a greater extent than repetitive shocks delivered at 15 or 60 second intervals [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Similar trends have been reported in humans, but the changes in impedance were not found to be clinically relevant [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. With repeated shocks, impedance decreased by as much as 8 percent and the peak current increased by 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/57\">",
"     57",
"    </a>",
"    ]. Therefore, despite only a minimally larger amount of energy being delivered to the heart, an unsuccessful shock should be followed promptly by a higher energy shock.",
"   </p>",
"   <p>",
"    An animal study examined the mechanisms responsible for the decline in transthoracic impedance after DC shocks [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/58\">",
"     58",
"    </a>",
"    ]. After three 100-joule shocks, there was an 11 percent decline in transthoracic impedance which correlated with a tenfold increase in skeletal muscle blood flow. This observation suggests that tissue edema contributes to the DC shock-induced decline in transthoracic impedance.",
"   </p>",
"   <p>",
"    A second report evaluated the effect of sternotomy on transthoracic impedance [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/59\">",
"     59",
"    </a>",
"    ]. Transthoracic impedance decreased after sternotomy and remained below preoperative measurements even after wound healing was complete, suggesting that the hyperemia, inflammation, tissue edema, and pleural effusion associated with sternotomy were the major contributors to the reduction in impedance.",
"   </p>",
"   <p>",
"    The phase of ventilation is another factor that alters transthoracic impedance. Inspiration (and the increased volume of air within the lungs) is associated with a 13 percent higher transthoracic impedance than expiration [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The composition of the gel used during cardioversion also affects the transthoracic impedance. In a study comparing a non-salt-containing gel to a salt-containing gel, transthoracic impedance was 20 percent higher with the non-salt-containing gel [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Type of arrhythmia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The type of arrhythmia and the patient's clinical condition are important determinants of defibrillation success [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. As an example, patients with ventricular fibrillation as the primary event are easier to defibrillate than patients with secondary ventricular fibrillation resulting from uncompensated congestive heart failure and hypotension.",
"   </p>",
"   <p>",
"    The different energy requirements between organized and non-organized arrhythmias may be related to the electrophysiologic characteristics of the arrhythmia. Organized arrhythmias, such as sustained monomorphic ventricular tachycardia, arise from a discrete reentrant circuit which is easily depolarized by smaller amounts of current [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. In contrast, in non-organized rhythms such as polymorphic ventricular tachycardia and ventricular fibrillation, the wavefronts are multiple and involve more myocardial mass, thereby requiring more energy for termination [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The electrical current and energy required to terminate ventricular tachyarrhythmias vary by arrhythmia. Ventricular tachycardia generally requires less energy than ventricular fibrillation. In one study of 203 patients who received 569 shocks for ventricular tachycardia or fibrillation, the heart rate and electrocardiographic degree of organization of the tachycardia were important determinants of transthoracic energy and the current requirements for cardioversion or defibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/67\">",
"     67",
"    </a>",
"    ]. Transthoracic termination of monomorphic ventricular tachycardia required relatively low energy (70 to 100 joules) while polymorphic ventricular tachycardia required more energy (150 to 200 joules).",
"   </p>",
"   <p>",
"    The varying energy requirements for cardioversion for ventricular tachyarrhythmias are analogous to those of atrial tachyarrhythmias. Atrial flutter, a more organized rhythm than atrial fibrillation, generally terminates with lower electrical doses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Duration of arrhythmia",
"    </span>",
"    &nbsp;&mdash;&nbsp;An additional factor in the likelihood of a successful cardioversion or defibrillation, for both ventricular and atrial arrhythmias, is the amount of time an arrhythmia has been present.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In ventricular fibrillation the duration of the arrhythmia is a determinant of the degree of organization of the electrical impulse. Even when using a biphasic waveform, the effectiveness of defibrillation is reduced when the arrhythmia is of longer duration [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/68\">",
"       68",
"      </a>",
"      ]. The more recent the onset of ventricular fibrillation, the coarser are the fibrillatory waves and the greater the success with defibrillation. As the arrhythmia persists (ie, more than 10 to 30 seconds), the fibrillatory waves become finer and the likelihood of successful termination decreases [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/69-71\">",
"       69-71",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      This relationship has also been demonstrated in a study of 22 patients with an implantable cardioverter-defibrillator [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/70\">",
"       70",
"      </a>",
"      ]. Defibrillation was effective in 82 percent of patients when delivered after five seconds compared to 45 percent when delivered after 15 seconds. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=see_link\">",
"       \"Outcome of sudden cardiac arrest\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In atrial fibrillation there is a similar relationship between duration of atrial fibrillation and the success of cardioversion, although longer time periods are usually involved. One study of 198 patients found that sinus rhythm was restored in 98 percent of patients when the duration of atrial fibrillation was less than 24 hours compared to a success rate of 62 percent when the duration was more than 24 hours [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/72\">",
"       72",
"      </a>",
"      ]. The overall success rate for sinus rhythm restoration is about 90 percent when atrial fibrillation is of less than one year's duration compared to 50 percent when atrial fibrillation has been present for more than five years [",
"      <a class=\"abstract\" href=\"UTD.htm?17/35/17977/abstract/73\">",
"       73",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6508517\">",
"    <span class=\"h3\">",
"     Patients with an underlying cardiac implantable electronic device",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with an underlying cardiac implantable electronic device (CIED) such as a permanent pacemaker or an implantable cardioverter-defibrillator require special attention to electrode placement. In such patients, we recommend placing the external electrode pads in the anteroposterior position and avoiding any contact with the skin overlying the CIED. Positioning of the electrode pads to avoid making contact with the skin overlying the CIED is critical to maximizing the efficacy of the externally delivered shock and minimizing the likelihood of damage to the CIED from the externally delivered shock.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ENERGY SELECTION FOR DEFIBRILLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The amount of energy selected for initial attempts of defibrillation has been controversial. The energy selected should be sufficient to accomplish prompt defibrillation because repeated failures expose the heart to damage from prolonged ischemia and multiple shocks. On the other hand, excessive energy should be avoided, since myocardial damage from high-energy shocks has been demonstrated in experimental studies, although the frequency with which this occurs in humans is not known. The choice of energy for initial attempts at cardioversion or defibrillation is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11050?source=see_link&amp;anchor=H2562597#H2562597\">",
"     \"Cardioversion for specific arrhythmias\", section on 'Energy selection for defibrillation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/10/24738?source=see_link\">",
"       \"Patient information: Cardioversion (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2817447\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrical cardioversion and defibrillation have become routine procedures in the management of patients with cardiac arrhythmias. Cardioversion is the delivery of energy that is synchronized to the QRS complex, while defibrillation is the non-synchronized delivery of a shock during the cardiac cycle. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardioversion terminates arrhythmias by delivering a synchronized shock that depolarizes the tissue involved in a reentrant circuit (",
"      <a class=\"graphic graphic_figure graphicRef52134 \" href=\"UTD.htm?9/50/10017\">",
"       figure 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef82249 \" href=\"UTD.htm?38/33/39441\">",
"       figure 3",
"      </a>",
"      ). By depolarizing all excitable tissue of the circuit and making the tissue refractory, the circuit is no longer able to propagate or sustain reentry. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Electrophysiology of defibrillation and cardioversion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Despite its widespread clinical use, controversy persists concerning the electrophysiologic mechanisms by which electrical cardioversion or defibrillation terminates atrial or ventricular fibrillation, arrhythmias which involve multiple microreentrant circuits. Most investigators agree that defibrillation occurs when a certain amount of current density reaches the myocardium. However, it is unclear what amount of current density is needed and what energy setting is necessary to achieve a homogeneous current density. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Electrophysiology of defibrillation and cardioversion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of device-related factors will influence the chances of successful cardioversion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      defibrillation, including electrode size and position, hand-held versus self-adhesive patch electrodes, and monophasic versus biphasic waveforms. (See",
"      <a class=\"local\" href=\"#H2817474\">",
"       'Device-related variables'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of patient-related factors also influence the chances of successful cardioversion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      defibrillation, including transthoracic impedance, type of arrhythmia, and the duration of arrhythmia. (See",
"      <a class=\"local\" href=\"#H2155703\">",
"       'Patient-related variables'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While the anteroposterior electrode position is suggested for most patients, for persons with an underlying cardiac implantable electronic device (CIED) such as a permanent pacemaker or an implantable cardioverter-defibrillator, we specifically recommend placing the external electrode pads in the anteroposterior position and avoiding any contact with the skin overlying the CIED. This placement should maximize the shock efficacy and minimize the likelihood of damage to the CIED. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Electrode position'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6508517\">",
"       'Patients with an underlying cardiac implantable electronic device'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2009114635\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and UpToDate would like to thank Dr. Philip Podrid, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/1\">",
"      ZOLL PM, LINENTHAL AJ, GIBSON W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med 1956; 254:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/2\">",
"      LOWN B, AMARASINGHAM R, NEUMAN J. New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. JAMA 1962; 182:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/3\">",
"      ALEXANDER S, KLEIGER R, LOWN B. Use of external electric countershock in the treatment of ventricular tachycardia. JAMA 1961; 177:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/4\">",
"      Zoll PM, Linentha AJ. Termination of refractory tachycardia by external countershock. Circulation 1962; 25:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/5\">",
"      PAUL MH, MILLER RA. External electrical termination of supraventricular arrhythmias in congenital heart disease. Circulation 1962; 25:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/6\">",
"      Kerber RE, Martins JB, Kienzle MG, et al. Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. Circulation 1988; 77:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/7\">",
"      Lerman BB, Halperin HR, Tsitlik JE, et al. Relationship between canine transthoracic impedance and defibrillation threshold. Evidence for current-based defibrillation. J Clin Invest 1987; 80:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/8\">",
"      Kerber RE, Jensen SR, Gascho JA, et al. Determinants of defibrillation: prospective analysis of 183 patients. Am J Cardiol 1983; 52:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/9\">",
"      Lerman BB, DiMarco JP, Haines DE. Current-based versus energy-based ventricular defibrillation: a prospective study. J Am Coll Cardiol 1988; 12:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/10\">",
"      Plonsey R, Barr RC. Effect of microscopic and macroscopic discontinuities on the response of cardiac tissue to defibrillating (stimulating) currents. Med Biol Eng Comput 1986; 24:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/11\">",
"      Mower MM, Mirowski M, Spear JF, Moore EN. Patterns of ventricular activity during catheter defibrillation. Circulation 1974; 49:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/12\">",
"      Witkowski FX, Penkoske PA, Plonsey R. Mechanism of cardiac defibrillation in open-chest dogs with unipolar DC-coupled simultaneous activation and shock potential recordings. Circulation 1990; 82:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/13\">",
"      Chen PS, Shibata N, Dixon EG, et al. Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks. J Clin Invest 1986; 77:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/14\">",
"      Zipes DP, Fischer J, King RM, et al. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol 1975; 36:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/15\">",
"      Chen PS, Wolf PD, Ideker RE. Mechanism of cardiac defibrillation. A different point of view. Circulation 1991; 84:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/16\">",
"      Witkowski FX, Kerber RE. Currently known mechanisms underlying direct current external and internal cardiac defibrillation. J Cardiovasc Electrophysiol 1991; 2:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/17\">",
"      Chen PS, Shibata N, Dixon EG, et al. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. Circulation 1986; 73:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/18\">",
"      Chen PS, Wolf PD, Melnick SD, et al. Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open-chest dogs. Circ Res 1990; 66:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/19\">",
"      Huang J, KenKnight BH, Walcott GP, et al. Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability. Circulation 1997; 96:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/20\">",
"      Sweeney RJ, Gill RM, Steinberg MI, Reid PR. Ventricular refractory period extension caused by defibrillation shocks. Circulation 1990; 82:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/21\">",
"      Zhou XH, Knisley SB, Wolf PD, et al. Prolongation of repolarization time by electric field stimulation with monophasic and biphasic shocks in open-chest dogs. Circ Res 1991; 68:1761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/22\">",
"      Moubarak JB, Karasik PE, Fletcher RD, Franz MR. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation. J Am Coll Cardiol 2000; 35:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/23\">",
"      LOWN B, KLEIGER R, WOLFF G. THE TECHNIQUE OF CARDIOVERSION. Am Heart J 1964; 67:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/24\">",
"      Botto GL, Politi A, Bonini W, et al. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart 1999; 82:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/25\">",
"      Kirchhof P, Eckardt L, Loh P, et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 2002; 360:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/26\">",
"      Myerburg RJ, Castellanos A. Electrode positioning for cardioversion of atrial fibrillation. Lancet 2002; 360:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/27\">",
"      Kerber RE, Jensen SR, Grayzel J, et al. Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. N Engl J Med 1981; 305:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/28\">",
"      Mathew TP, Moore A, McIntyre M, et al. Randomised comparison of electrode positions for cardioversion of atrial fibrillation. Heart 1999; 81:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/29\">",
"      Walsh SJ, McCarty D, McClelland AJ, et al. Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions. Eur Heart J 2005; 26:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/30\">",
"      Thomas ED, Ewy GA, Dahl CF, Ewy MD. Effectiveness of direct current defibrillation: role of paddle electrode size. Am Heart J 1977; 93:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/31\">",
"      Ewy GA, Horan WJ. Effectiveness of direct current defibrillation: role of paddle electrode size: II. Am Heart J 1977; 93:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/32\">",
"      Dalzell GW, Cunningham SR, Anderson J, Adgey AA. Electrode pad size, transthoracic impedance and success of external ventricular defibrillation. Am J Cardiol 1989; 64:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/33\">",
"      Kugelberg J. The interelectrode electrical resistance at defibrillation. Scand J Thorac Cardiovasc Surg 1972; 6:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/34\">",
"      Ewy GA, Taren D. Impedance to transthoracic direct current discharge: a model for testing interface material. Med Instrum 1978; 12:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/35\">",
"      Dahl CF, Ewy GA, Warner ED, Thomas ED. Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation 1974; 50:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/36\">",
"      Hoyt R, Grayzel J, Kerber RE. Determinants of intracardiac current in defibrillation. Experimental studies in dogs. Circulation 1981; 64:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/37\">",
"      Kirchhof P, M&ouml;nnig G, Wasmer K, et al. A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA). Eur Heart J 2005; 26:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/38\">",
"      Schuder JC, McDaniel WC, Stoeckle H. Defibrillation of 100 kg calves with asymmetrical, bidirectional, rectangular pulses. Cardiovasc Res 1984; 18:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/39\">",
"      Walcott GP, Melnick SB, Chapman FW, et al. Relative efficacy of monophasic and biphasic waveforms for transthoracic defibrillation after short and long durations of ventricular fibrillation. Circulation 1998; 98:2210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/40\">",
"      Leng CT, Paradis NA, Calkins H, et al. Resuscitation after prolonged ventricular fibrillation with use of monophasic and biphasic waveform pulses for external defibrillation. Circulation 2000; 101:2968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/41\">",
"      Jones JL, Jones RE. Improved defibrillator waveform safety factor with biphasic waveforms. Am J Physiol 1983; 245:H60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/42\">",
"      Niemann JT, Burian D, Garner D, Lewis RJ. Monophasic versus biphasic transthoracic countershock after prolonged ventricular fibrillation in a swine model. J Am Coll Cardiol 2000; 36:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/43\">",
"      Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Optimized Response to Cardiac Arrest (ORCA) Investigators. Circulation 2000; 102:1780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/44\">",
"      Mittal S, Ayati S, Stein KM, et al. Comparison of a novel rectilinear biphasic waveform with a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. ZOLL Investigators. J Am Coll Cardiol 1999; 34:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/45\">",
"      Mittal S, Ayati S, Stein KM, et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000; 101:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/46\">",
"      Page RL, Kerber RE, Russell JK, et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol 2002; 39:1956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/47\">",
"      Niebauer MJ, Brewer JE, Chung MK, Tchou PJ. Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter. Am J Cardiol 2004; 93:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/48\">",
"      Morrison LJ, Dorian P, Long J, et al. Out-of-hospital cardiac arrest rectilinear biphasic to monophasic damped sine defibrillation waveforms with advanced life support intervention trial (ORBIT). Resuscitation 2005; 66:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/49\">",
"      Kudenchuk PJ, Cobb LA, Copass MK, et al. Transthoracic incremental monophasic versus biphasic defibrillation by emergency responders (TIMBER): a randomized comparison of monophasic with biphasic waveform ascending energy defibrillation for the resuscitation of out-of-hospital cardiac arrest due to ventricular fibrillation. Circulation 2006; 114:2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/50\">",
"      Mortensen K, Risius T, Schwemer TF, et al. Biphasic versus monophasic shock for external cardioversion of atrial flutter: a prospective, randomized trial. Cardiology 2008; 111:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/51\">",
"      Niebauer MJ, Chung MK, Brewer JE, Tchou PJ. Reduced cardioversion thresholds for atrial fibrillation and flutter using the rectilinear biphasic waveform. J Interv Card Electrophysiol 2005; 13:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/52\">",
"      Stiell IG, Walker RG, Nesbitt LP, et al. BIPHASIC Trial: a randomized comparison of fixed lower versus escalating higher energy levels for defibrillation in out-of-hospital cardiac arrest. Circulation 2007; 115:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/53\">",
"      Deale OC, Lerman BB. Intrathoracic current flow during transthoracic defibrillation in dogs. Transcardiac current fraction. Circ Res 1990; 67:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/54\">",
"      Dahl CF, Ewy GA, Ewy MD, Thomas ED. Transthoracic impedance to direct current discharge: effect of repeated countershocks. Med Instrum 1976; 10:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/55\">",
"      Geddes LA, Tacker WA, Cabler P, et al. The decrease in transthoracic impedance during successive ventricular defibrillation trials. Med Instrum 1975; 9:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/56\">",
"      Kerber RE, Grayzel J, Hoyt R, et al. Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 1981; 63:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/57\">",
"      Fumagalli S, Tarantini F, Caldi F, et al. Multiple shocks affect thoracic electrical impedance during external cardioversion of atrial fibrillation. Pacing Clin Electrophysiol 2009; 32:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/58\">",
"      Sirna SJ, Kieso RA, Fox-Eastham KJ, et al. Mechanisms responsible for decline in transthoracic impedance after DC shocks. Am J Physiol 1989; 257:H1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/59\">",
"      Kerber RE, Vance S, Schomer SJ, et al. Transthoracic defibrillation: effect of sternotomy on chest impedance. J Am Coll Cardiol 1992; 20:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/60\">",
"      Ewy GA, Hellman DA, McClung S, Taren D. Influence of ventilation phase on transthoracic impedance and defibrillation effectiveness. Crit Care Med 1980; 8:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/61\">",
"      Ewy GA, Taren D. Comparison of paddle electrode pastes used for defibrillation. Heart Lung 1977; 6:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/62\">",
"      Crampton R. Accepted, controversial, and speculative aspects of ventricular defibrillation. Prog Cardiovasc Dis 1980; 23:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/63\">",
"      Gascho JA, Crampton RS, Cherwek ML, et al. Determinants of ventricular defibrillation in adults. Circulation 1979; 60:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/64\">",
"      Link MS, Atkins DL, Passman RS, et al. Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/65\">",
"      Winkle RA, Stinson EB, Bach SM Jr, et al. Measurement of cardioversion/defibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration. Circulation 1984; 69:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/66\">",
"      Kienzle MG, Miller J, Falcone RA, et al. Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia. Circulation 1984; 70:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/67\">",
"      Kerber RE, Kienzle MG, Olshansky B, et al. Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion. Circulation 1992; 85:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/68\">",
"      Windecker S, Ideker RE, Plumb VJ, et al. The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans. J Am Coll Cardiol 1999; 33:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/69\">",
"      Dalzell GW, Adgey AA. Determinants of successful transthoracic defibrillation and outcome in ventricular fibrillation. Br Heart J 1991; 65:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/70\">",
"      Winkle RA, Mead RH, Ruder MA, et al. Effect of duration of ventricular fibrillation on defibrillation efficacy in humans. Circulation 1990; 81:1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/71\">",
"      Weaver WD, Cobb LA, Copass MK, Hallstrom AP. Ventricular defibrillation -- a comparative trial using 175-J and 320-J shocks. N Engl J Med 1982; 307:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/72\">",
"      Ricard P, L&eacute;vy S, Trigano J, et al. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997; 79:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/35/17977/abstract/73\">",
"      Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967; 29:469.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 975 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-4DC6258CCE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17977=[""].join("\n");
var outline_f17_35_17977=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2817447\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ELECTROPHYSIOLOGY OF DEFIBRILLATION AND CARDIOVERSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      FACTORS AFFECTING DEFIBRILLATION AND CARDIOVERSION SUCCESS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2817474\">",
"      Device-related variables",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Electrodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Electrode position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pad size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hand-held versus patch",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Monophasic versus biphasic waveforms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Ventricular fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Optimal biphasic defibrillation energies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2155703\">",
"      Patient-related variables",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Transthoracic impedance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Type of arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Duration of arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6508517\">",
"      - Patients with an underlying cardiac implantable electronic device",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ENERGY SELECTION FOR DEFIBRILLATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2817447\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2009114635\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/975\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/975|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/36/24140\" title=\"figure 1\">",
"      Defibrillation waveforms in ICDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/50/10017\" title=\"figure 2\">",
"      Mechanisms of reentry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/33/39441\" title=\"figure 3\">",
"      Sites of reentry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/13/10448\" title=\"figure 4\">",
"      Anterior and lateral defib pad placement",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25208?source=related_link\">",
"      Automated external defibrillators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11050?source=related_link\">",
"      Cardioversion for specific arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=related_link\">",
"      Outcome of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=related_link\">",
"      Pathophysiology and etiology of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/10/24738?source=related_link\">",
"      Patient information: Cardioversion (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34618?source=related_link\">",
"      Procedural sedation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/62/42984?source=related_link\">",
"      Reentry and the development of cardiac arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=related_link\">",
"      The electrocardiogram in atrial fibrillation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_35_17978="Urothelial dysplasia A";
var content_f17_35_17978=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60337%7EONC%2F69993%7EONC%2F81871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60337%7EONC%2F69993%7EONC%2F81871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Urothelial dysplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 229px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cristina Magi-Galluzzi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urothelial dysplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cristina Magi-Galluzzi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urothelial dysplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cristina Magi-Galluzzi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17978=[""].join("\n");
var outline_f17_35_17978=null;
var title_f17_35_17979="Echo symptomatic murmurs";
var content_f17_35_17979=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Echocardiography in symptomatic patients with cardiac murmurs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class I - There is evidence and/or general agreement that echocardiography is useful in symptomatic patients with heart murmurs who also have one or more of the following",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Symptoms or signs of heart failure",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Myocardial ischemia or infarction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Syncope",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Thromboembolism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Infective endocarditis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Other evidence of structural heart disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class IIa - The weight of evidence or opinion is in favor of the usefulness of echocardiography in the following patients with heart murmurs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Symptoms or signs are probably noncardiac in origin but a cardiac cause cannot be excluded by standard evaluation.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006; 48:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17979=[""].join("\n");
var outline_f17_35_17979=null;
var title_f17_35_17980="AIP response to treatment";
var content_f17_35_17980=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F83587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F83587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis: Response to treatment",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Initial response to corticosteroids",
"       </td>",
"       <td class=\"subtitle1\">",
"        Relapse",
"       </td>",
"       <td class=\"subtitle1\">",
"        Response to azathioprine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Bile duct strictures - response to azathioprine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Raina 2009",
"         <sup>",
"          [1]",
"         </sup>",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        15/19",
"       </td>",
"       <td class=\"centered\">",
"        9/15",
"       </td>",
"       <td class=\"centered\">",
"        9/15",
"       </td>",
"       <td class=\"centered\">",
"        6/9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Ghazale 2008",
"         <sup>",
"          [2]",
"         </sup>",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        29/30",
"        <br/>",
"        IAC",
"       </td>",
"       <td class=\"centered\">",
"        12/17",
"       </td>",
"       <td class=\"centered\">",
"        7/12",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Sandanayake 2009",
"         <sup>",
"          [3]",
"         </sup>",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        23/28",
"        <br/>",
"        IAC",
"       </td>",
"       <td class=\"centered\">",
"        13/23",
"       </td>",
"       <td class=\"centered\">",
"        7/23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Overall response",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        67/77",
"        <br/>",
"        (87 percent)",
"       </td>",
"       <td class=\"centered\">",
"        34/55",
"        <br/>",
"        (61.8 percent)",
"       </td>",
"       <td class=\"centered\">",
"        23/50",
"        <br/>",
"        (46 percent)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IAC: IgG4 associated cholangitis.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009; 104:2295.",
"       </li>",
"       <li>",
"        Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134:706.",
"       </li>",
"       <li>",
"        Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7:1089.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17980=[""].join("\n");
var outline_f17_35_17980=null;
var title_f17_35_17981="Oral agents for mild to moderate diabetic foot infections";
var content_f17_35_17981=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Oral agents for empiric treatment of mild to moderate diabetic foot infections",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        SINGLE-drug regimens with activity against streptococci and staphylococci (MSSA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Cephalexin",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Dicloxacillin",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        <p>",
"         Amoxicillin-clavulanate",
"         <strong>",
"          or",
"         </strong>",
"         clindamycin",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        TWO-drug regimens with activity against streptococci and MRSA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Clindamycin*",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Linezolid",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        <p>",
"         Penicillin",
"         <strong>",
"          or",
"         </strong>",
"         cefazolin",
"         <strong>",
"          or",
"         </strong>",
"         dicloxacillin",
"        </p>",
"        <p>",
"         <strong>",
"          PLUS",
"         </strong>",
"        </p>",
"        Trimethoprim-sulfamethoxazole",
"        <strong>",
"         or",
"        </strong>",
"        doxycycline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        TWO-drug regimens with activity against streptococci, MRSA, aerobic gram-negative bacilli and anaerobes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        <p>",
"         Trimethoprim-sulfamethoxazole",
"        </p>",
"        <p>",
"         <strong>",
"          PLUS",
"         </strong>",
"        </p>",
"        <p>",
"         Amoxicillin-clavulanate",
"        </p>",
"        <p>",
"         <strong>",
"          -OR-",
"         </strong>",
"        </p>",
"        <p>",
"         Clindamycin",
"        </p>",
"        <p>",
"         <strong>",
"          PLUS",
"         </strong>",
"        </p>",
"        <p>",
"         Ciprofloxacin",
"         <strong>",
"          or",
"         </strong>",
"         levofloxacin",
"         <strong>",
"          or",
"         </strong>",
"         moxifloxacin",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Antibiotic dosing for adults",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cephalexin",
"       </td>",
"       <td class=\"sublist_other\">",
"        500 mg every 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Dicloxacillin",
"       </td>",
"       <td class=\"sublist_other\">",
"        500 mg every 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Clindamycin",
"       </td>",
"       <td class=\"sublist_other\">",
"        300 to 450 mg every 6 to 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Linezolid",
"       </td>",
"       <td class=\"sublist_other\">",
"        600 mg every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Penicillin V potassium",
"       </td>",
"       <td class=\"sublist_other\">",
"        500 mg every 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Trimethoprim-sulfamethoxazole (co-trimoxazole)",
"       </td>",
"       <td class=\"sublist_other\">",
"        2 double-strength tablets (trimethoprim 160 mg and sulfamethoxazole 800 mg per tablet)&nbsp;every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Doxycycline",
"       </td>",
"       <td class=\"sublist_other\">",
"        100 mg orally every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Amoxicillin-clavulanate",
"       </td>",
"       <td class=\"sublist_other\">",
"        875/125 mg every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ciprofloxacin",
"       </td>",
"       <td class=\"sublist_other\">",
"        750 mg every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Levofloxacin",
"       </td>",
"       <td class=\"sublist_other\">",
"        750 mg every 24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Moxifloxacin",
"       </td>",
"       <td class=\"sublist_other\">",
"        400 mg every 24 hours",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MSSA: methicillin-susecptible staphylococcus aureus; MRSA: methicillin-resistant staphylococcus aureus.",
"     <br>",
"      * Check susceptibility testing.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Many of these agents require adjustment of the dose in the setting of renal dysfunction.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data courtesy of authors with additional data from: Lipsky BA, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;&nbsp;54:e132.&nbsp;&nbsp;",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17981=[""].join("\n");
var outline_f17_35_17981=null;
var title_f17_35_17982="Effects of parathyroidectomy";
var content_f17_35_17982=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F72139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F72139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Graph showing the changes in total plasma calcium and phosphate concentrations after parathyroidectomy for secondary hyperparathyroidism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 210px; height: 202px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Changes in total plasma calcium and phosphate levels observed in 11 uremic patients before and following subtotal parathyroidectomy (PTX) for severe secondary hyperparathyroidism.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Massry SG, Coburn JW, Popovtzer MM, Arch Intern Med 1969; 124:431. Copyright 1969, American Medical Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17982=[""].join("\n");
var outline_f17_35_17982=null;
var title_f17_35_17983="2D TTE Anteriorly angulated 2-chamber view";
var content_f17_35_17983=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) from an anteriorly angulated two-chamber view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 283px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In some patients anterior angulation of the two chamber view affords the best view of the geometry of the left ventricular outflow tract. This advantage is especially true in hypertrophic cardiomyopathy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_35_17983=[""].join("\n");
var outline_f17_35_17983=null;
